EurekaMag Full Text Articles Chapter 56,551

Miyamoto, K.; Ohtaki, H.; Dohi, K.; Tsumuraya, T.; Song, D.; Kiriyama, K.; Satoh, K.; Shimizu, A.; Aruga, T.; Shioda, S. 2013: Therapeutic time window for edaravone treatment of traumatic brain injury in mice. Biomed Research International 2013: 379206

Abe, K. 2011: Therapeutic time window for ischemic stroke. Rinsho Shinkeigaku 51(11): 1182-1184

Yang, J.-P.; Liu, H.-J.; Yang, H.; Feng, P.-Y. 2011: Therapeutic time window for the neuroprotective effects of NGF when administered after focal cerebral ischemia. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 32(3): 433-441

An, Y.T.; Zhao, Z.; Sheng, Y.C.; Min, Y.; Xia, Y.Y. 2011: Therapeutic time window of YGY-E neuroprotection of cerebral ischemic injury in rats. Drug Discoveries and Therapeutics 5(2): 76-83

Hayakawa, K.; Irie, K.; Sano, K.; Watanabe, T.; Higuchi, S.; Enoki, M.; Nakano, T.; Harada, K.; Ishikane, S.; Ikeda, T.; Fujioka, M.; Orito, K.; Iwasaki, K.; Mishima, K.; Fujiwara, M. 2009: Therapeutic time window of cannabidiol treatment on delayed ischemic damage via high-mobility group box1-inhibiting mechanism. Biological and Pharmaceutical Bulletin 32(9): 1538-1544

Wang, C.; Liu, J.-l.; Sang, H.-f.; Lu, Y.; Dong, H.-l.; Xiong, L.-z. 2008: Therapeutic time window of flurbiprofen axetil's neuroprotective effect in a rat model of transient focal cerebral ischemia. Chinese Medical Journal 121(24): 2572-2577

Ji, Y.; Hu, Y.; Wu, Y.; Ji, Z.; Song, W.; Wang, S.; Pan, S. 2012: Therapeutic time window of hypothermia is broader than cerebral artery flushing in carotid saline infusion after transient focal ischemic stroke in rats. Neurological Research 34(7): 657-663

Xu, Z.-H.; Wu, D.-C.; Fang, Q.; Zhong, K.; Wang, S.; Sun, H.-L.; Zhang, S.-H.; Chen, Z. 2010: Therapeutic time window of low-frequency stimulation at entorhinal cortex for amygdaloid-kindling seizures in rats. Epilepsia 51(9): 1861-1864

Komatsu, K.; Honmou, O.; Suzuki, J.; Houkin, K.; Hamada, H.; Kocsis, J.D. 2010: Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia. Brain Research 1334: 84-92

Andrade, D.C.; Borges, I.; Bravo, G.L.; Bolognini, N.; Fregni, F. 2013: Therapeutic time window of noninvasive brain stimulation for pain treatment: inhibition of maladaptive plasticity with early intervention. Expert Review of Medical Devices 10(3): 339-352

Scarpioni, R. 2009: Therapeutic tools for dyslipidemia in peritoneal dialysis patients. Journal of Nephrology 22(1): 46-58

Lavogiez-Dermaux, C.; Delaporte, E.; Mordon, S. 2013: Therapeutic tools for port-wine stains. Annales de Dermatologie et de Venereologie 140(3): 226-233; Quiz 225, 234

Hoimes, C.J.; Strimpakos, A.S.; Saif, M.W. 2009: Therapeutic tools in pancreatic cancer. Jop: Journal of the Pancreas 10(2): 118-122

Hawranik, P.; Johnston, P.; Deatrich, J. 2008: Therapeutic touch and agitation in individuals with Alzheimer's disease. Western Journal of Nursing Research 30(4): 417-434

Robinson, J.; Biley, F.C.; Dolk, H. 2007: Therapeutic touch for anxiety disorders. Cochrane Database of Systematic Reviews 3: Cd006240

Wallrabenstein, R. 2012: Therapeutic touch for demented patients with pain. Healing with the hands. Pflege Zeitschrift 65(3): 160-162

O'Mathúna, D.ón.P.; Ashford, R.L. 2012: Therapeutic touch for healing acute wounds. Cochrane Database of Systematic Reviews 6: Cd002766

O'Mathúna, D.ón.P.; Ashford, R.L. 2014: Therapeutic touch for healing acute wounds. Cochrane Database of Systematic Reviews 7: Cd002766

Johnston, C.; Campbell-Yeo, M.; Rich, B.; Whitley, J.; Filion, F.; Cogan, J.; Walker, C.-D. 2013: Therapeutic touch is not therapeutic for procedural pain in very preterm neonates: a randomized trial. Clinical Journal of Pain 29(9): 824-829

Gronowicz, G.A.; Jhaveri, A.; Clarke, L.W.; Aronow, M.S.; Smith, T.H. 2008: Therapeutic touch stimulates the proliferation of human cells in culture. Journal of Alternative and Complementary Medicine 14(3): 233-239

Hanley, M.A. 2008: Therapeutic touch with preterm infants: composing a treatment. Explore 4(4): 249-258

Rose, R. 2014: Therapeutic touch. a nursing intervention as a chance - also for personal health care. Kinderkrankenschwester: Organ der Sektion Kinderkrankenpflege 33(7): 285-287

Ramada, N.C.O.; Almeida, F.d.A.; Cunha, M.L.d.R. 2013: Therapeutic touch: influence on vital signs of newborns. Einstein 11(4): 421-425

Lee, T.Yan.Alexander. 2004: Therapeutic touch: the conventional versus the alternative. Australian Journal of Holistic Nursing 11(1): 33-36

Ohlsson, H.; Chaix, B.; Merlo, J. 2009: Therapeutic traditions, patient socioeconomic characteristics and physicians' early new drug prescribing--a multilevel analysis of rosuvastatin prescription in south Sweden. European Journal of Clinical Pharmacology 65(2): 141-150

Bannuru, R.R.; Natov, N.S.; Dasi, U.R.; Schmid, C.H.; McAlindon, T.E. 2011: Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis--meta-analysis. Osteoarthritis and Cartilage 19(6): 611-619

Bannuru, R.R.; Natov, N.S.; Obadan, I.E.; Price, L.L.; Schmid, C.H.; McAlindon, T.E. 2009: Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis and Rheumatism 61(12): 1704-1711

McComas, A.; Upton, A. 2009: Therapeutic transcranial magnetic stimulation in migraine and its implications for a neuroinflammatory hypothesis. Inflammopharmacology 17(2): 68-75

Cooke, J.P. 2013: Therapeutic transdifferentiation: a novel approach for vascular disease. Circulation Research 112(5): 748-750

Sayed, N.; Wong, W.T.; Cooke, J.P. 2013: Therapeutic transdifferentiation: can we generate cardiac tissue rather than scar after myocardial injury?. Methodist Debakey Cardiovascular Journal 9(4): 210-212

Canda, E.R. 1988: Therapeutic transformation in ritual, therapy, and human development. Journal of Religion and Health 27(3): 205-220

Liu, G.-P.; Zhu, W.-X.; Cheng, G.-M.; Ma, S.-R. 2013: Therapeutic transjejunal endoscopy for the treatment of biliary complications after choledochojejunostomy. Experimental and Therapeutic Medicine 5(2): 499-502

Molitoris, B.A. 2014: Therapeutic translation in acute kidney injury: the epithelial/endothelial axis. Journal of Clinical Investigation 124(6): 2355-2363

Geisbert, T.W.; Mire, C.E.; Geisbert, J.B.; Chan, Y.-P.; Agans, K.N.; Feldmann, F.; Fenton, K.A.; Zhu, Z.; Dimitrov, D.S.; Scott, D.P.; Bossart, K.N.; Feldmann, H.; Broder, C.C. 2014: Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody. Science Translational Medicine 6(242): 242ra82

Edwards, S.J.; Brownlee, A. 1946: Therapeutic treatment of bovine mastitis. Veterinary Record 58: 335-343

Gupta, R.; Chaudhary, A.R.; Shah, B.N.; Jadhav, A.V.; Zambad, S.P.; Gupta, R.C.; Deshpande, S.; Chauthaiwale, V.; Dutt, C. 2014: Therapeutic treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates murine colitis. Clinical and Experimental Gastroenterology 7: 13-23

Luan, Z.-G.; Zhang, H.; Ma, X.-C.; Zhang, C.; Guo, R.-X. 2012: Therapeutic treatment with ethyl pyruvate attenuates the severity of liver injury in rats with severe acute pancreatitis. Pancreas 41(5): 729-737

Bir, S.C.; Esaki, J.; Marui, A.; Sakaguchi, H.; Kevil, C.G.; Ikeda, T.; Komeda, M.; Tabata, Y.; Sakata, R. 2011: Therapeutic treatment with sustained-release platelet-rich plasma restores blood perfusion by augmenting ischemia-induced angiogenesis and arteriogenesis in diabetic mice. Journal of Vascular Research 48(3): 195-205

Chiaratti, M.R.; Meirelles, F.áv.V.; Wells, D.; Poulton, J. 2011: Therapeutic treatments of mtDNA diseases at the earliest stages of human development. Mitochondrion 11(5): 820-828

Yuzuriha, T. 2010: Therapeutic trends in alcohol-related disorders. Seishin Shinkeigaku Zasshi 112(8): 793-796

Watari, J.; Sakurai, J.; Morita, T.; Oshima, T.; Hori, K.; Miwa, H. 2009: Therapeutic trends of diseases of the upper gastrointestinal tract in patients with negative H. pylori status. Nihon Rinsho. Japanese Journal of Clinical Medicine 67(12): 2378-2386

Ichikawa, Y.; Goto, J.; Nakahara, Y.; Mitsui, J.; Tsuji, S. 2011: Therapeutic trial design issues for future disease-modifying therapy of multiple system atrophy. Rinsho Shinkeigaku 51(11): 910-913

Aguado Ortega, R.; Bermejo Boixareu, C.; Gómez-Pavón, J.; May Priego, M.; Sarro Cañizares, M.ón.; Ruipérez Cantera, I. 2008: Therapeutic trial in suspected bronchiolitis obliterans organizing pneumonia (BOOP) in the elderly. Revista Espanola de Geriatria y Gerontologia 43(6): 379-383

Lee, J.W.; Shin, H.I.; Park, S.Y.; Lee, G.Y.; Kang, H.S. 2010: Therapeutic trial of fluoroscopic interlaminar epidural steroid injection for axial low back pain: effectiveness and outcome predictors. AJNR. American Journal of Neuroradiology 31(10): 1817-1823

Winslow, D.L. 2008: Therapeutic trial of growth hormone releasing factor in HIV patients. Aids Alert 23(4): 45-46

Auricchio, N.; Malinowska, I.; Shaw, R.; Manning, B.D.; Kwiatkowski, D.J. 2012: Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC). Plos one 7(2): E31900

Lewis, L. 1946: Therapeutic trial of penicillin in tetanus. Annals of Internal Medicine 25(6): 903-915

Rathi, S.K.; Pandhi, R.K.; Khanna, N.; Chopra, P. 2003: Therapeutic trial of sodium antimony gluconate alone and in combination with ketoconazole in post-kala-azar dermal leishmaniasis. Indian Journal of Dermatology Venereology and Leprology 69(6): 392-393

Thompson, A.; Antel, J.; Carroll, W. 2012: Therapeutic trial outcome studies. Multiple Sclerosis 18(7): 913

Raff, M.; Tokumoto, Y.; Tang, D. 2001: Control of Cell Survival and Proliferation in the Oligodendrocyte Cell Lineage. Thescientificworldjournal 1: 90

Sardana, K.; Garg, V.K. 2008: Therapeutic trials for systemic sclerosis: an update. Indian Journal of Dermatology Venereology and Leprology 74(5): 436-446

Zerr, I. 2009: Therapeutic trials in human transmissible spongiform encephalo-pathies: recent advances and problems to address. Infectious Disorders Drug Targets 9(1): 92-99

Ratziu, V.; Caldwell, S.; Neuschwander-Tetri, B.A. 2010: Therapeutic trials in nonalcoholic steatohepatitis: insulin sensitizers and related methodological issues. Hepatology 52(6): 2206-2215

Guillaume, S.; Koné-Paut, I. 2008: Therapeutic trials in paediatric rheumatology. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 15(5): 867-869

Ghosh, S.; Seshadri, R.; Jain, K.C. 1971: Evaluation of corticosteroids in treatment of tuberculous meningitis. Archives of Disease in Childhood 46(245): 51-54

Sonkin, L.S. 1997: Therapeutic trials with thyroid hormones in chemically euthyroid patients with myofascial pain and complaints suggesting mild thyroid insufficiency. Journal of Back and Musculoskeletal Rehabilitation 8(2): 165-171

Yan, F.; Li, X.; Jin, Q.; Jiang, C.; Zhang, Z.; Ling, T.; Qiu, B.; Zheng, H. 2011: Therapeutic ultrasonic microbubbles carrying paclitaxel and LyP-1 peptide: preparation, characterization and application to ultrasound-assisted chemotherapy in breast cancer cells. Ultrasound in Medicine and Biology 37(5): 768-779

Mason, T.J. 2011: Therapeutic ultrasound an overview. Ultrasonics Sonochemistry 18(4): 847-852

Muftic, M.; Miladinovic, K. 2013: Therapeutic ultrasound and pain in degenerative diseases of musculoskeletal system. Acta Informatica Medica: Aim: Journal of the Society for Medical Informatics of Bosnia and Herzegovina: Casopis Drustva Za Medicinsku Informatiku Bih 21(3): 170-172

Wylie, M.P.; McGuinness, G.B.; Gavin, G.P. 2009: Therapeutic ultrasound angioplasty: the risk of arterial perforation. An in vitro study. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2009: 282-285

El-Bialy, T. 2007: Therapeutic ultrasound applications in craniofacial growth, healing and tissue engineering. Rejuvenation Research 10(3): 367-371

Bartley, J.; Ansari, N.N.; Naghdi, S. 2014: Therapeutic ultrasound as a treatment modality for chronic rhinosinusitis. Current Infectious Disease Reports 16(3): 398

Young, D.; Morton, R.; Bartley, J. 2010: Therapeutic ultrasound as treatment for chronic rhinosinusitis: preliminary observations. Journal of Laryngology and Otology 124(5): 495-499

Mahoney, C.M.; Morgan, M.R.; Harrison, A.; Humphries, M.J.; Bass, M.D. 2009: Therapeutic ultrasound bypasses canonical syndecan-4 signaling to activate rac1. Journal of Biological Chemistry 284(13): 8898-8909

Weiss, M. 2012: Therapeutic ultrasound clarifies suspicion. Sportverletzung Sportschaden: Organ der Gesellschaft für Orthopadisch-Traumatologische Sportmedizin 26(2): 57

McBrier, N.M.; Lekan, J.M.; Druhan, L.J.; Devor, S.T.; Merrick, M.A. 2007: Therapeutic ultrasound decreases mechano-growth factor messenger ribonucleic acid expression after muscle contusion injury. Archives of Physical Medicine and Rehabilitation 88(7): 936-940

Oliveira, R.d.P.; Elias, M.A.él.F.; Bellei, P.M.; Silveira, S.âm.M.d.C.; Peters, V.M.; Guerra, M.d.O. 2008: Therapeutic ultrasound effect on pregnant rats. Revista Brasileira de Ginecologia e Obstetricia: Revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 30(7): 335-340

Van den Bekerom, M.P.J.; van der Windt, D.A.W.M.; Ter Riet, G.; van der Heijden, G.J.; Bouter, L.M. 2012: Therapeutic ultrasound for acute ankle sprains. European Journal of Physical and Rehabilitation Medicine 48(2): 325-334

Page, M.J.; O'Connor, D.; Pitt, V.; Massy-Westropp, N. 2013: Therapeutic ultrasound for carpal tunnel syndrome. Cochrane Database of Systematic Reviews 3: Cd009601

Ebadi, S.; Henschke, N.; Nakhostin Ansari, N.; Fallah, E.; van Tulder, M.W. 2014: Therapeutic ultrasound for chronic low-back pain. Cochrane Database of Systematic Reviews 3: Cd009169

Scheven, B.A.A.; Shelton, R.M.; Cooper, P.R.; Walmsley, A.D.; Smith, A.J. 2009: Therapeutic ultrasound for dental tissue repair. Medical Hypotheses 73(4): 591-593

Rutjes, A.W.; Nüesch, E.; Sterchi, R.; Jüni, P. 2010: Therapeutic ultrasound for osteoarthritis of the knee or hip. Cochrane Database of Systematic Reviews 1: Cd003132

Al-Kurdi, D.; Bell-Syer, S.E.M.; Flemming, K. 2008: Therapeutic ultrasound for venous leg ulcers. Cochrane Database of Systematic Reviews 1: Cd001180

Cullum, N.A.; Al-Kurdi, D.; Bell-Syer, S.E. 2010: Therapeutic ultrasound for venous leg ulcers. Cochrane Database of Systematic Reviews 6: Cd001180

Grubisić, F.; Grazio, S.; Jajić, Z.; Nemcić, T. 2006: Therapeutic ultrasound in chronic low back pain treatment. Reumatizam 53(1): 18-21

John, P.S.; Poulose, C.S.; George, B. 2008: Therapeutic ultrasound in fracture healing: the mechanism of osteoinduction. Indian Journal of Orthopaedics 42(4): 444-447

Lioce, E.E.A.N.; Novello, M.; Durando, G.; Bistolfi, A.; Actis, M.V.; Massazza, G.; Magnetto, C.; Guiot, C. 2014: Therapeutic ultrasound in physical medicine and rehabilitation: characterization and assessment of its physical effects on joint-mimicking phantoms. Ultrasound in Medicine and Biology 40(11): 2743-2748

Shellshear, M. 1981: Therapeutic ultrasound in post-partum breast engorgement. Australian Journal of PhysioTherapy 27(1): 15-16

Ansari, N.N.; Naghdi, S.; Bagheri, H.; Ghassabi, H. 2007: Therapeutic ultrasound in the treatment of ankle plantarflexor spasticity in a unilateral stroke population: a randomized, single-blind, placebo-controlled trial. Electromyography and Clinical Neurophysiology 47(3): 137-143

Nedelmann, M.; Gerriets, T.; Kaps, M. 2008: Therapeutic ultrasound of acute cerebral artery occlusion. Der Nervenarzt 79(12): 1399-1400; 1402-1406

Owens, G.E.; Miller, R.M.; Ensing, G.; Ives, K.; Gordon, D.; Ludomirsky, A.; Xu, Z. 2011: Therapeutic ultrasound to noninvasively create intracardiac communications in an intact animal model. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 77(4): 580-588

Xuedong Shen; Nair, C.; Holmberg, M.; Mooss, A.; Arouni, A.; Esterbrooks, D. 2010: Therapeutic ultrasound-enhanced thrombolysis in patients with acute myocardial infarction. Angiology 61(3): 253-258

Fyfe, M.C.; Bullock, M.I. 1985: Therapeutic ultrasound: some historical background and development in knowledge of its effect on healing. Australian Journal of PhysioTherapy 31(6): 220-224

Edwards, C.; Anstey, A.V. 2010: Therapeutic ultraviolet light-emitting diode sources: a new phase in the evolution of phototherapy. British Journal of Dermatology 163(1): 3-4

Durupt, S.; Nove Josserand, R.; Durieu, I. 2014: Therapeutic update in cystic fibrosis. La Revue de Medecine Interne 35(6): 388-392

Belaiche, J.; Delwaide, J.; Polus, M.; Louis, E. 2007: Therapeutic update in gastroenterology. Revue Medicale de Liege 62(5-6): 303-309

Chan, A.L.; Rafii, R.; Louie, S.; Albertson, T.E. 2013: Therapeutic update in idiopathic pulmonary fibrosis. Clinical Reviews in Allergy and Immunology 44(1): 65-74

Pérez-Esteban, S.; González-Gay, M.A.; Castañeda, S. 2013: Therapeutic update in large vessel vasculitides. Revista Clinica Espanola 213(7): 338-346

Louis, R.; Bosquée, L.; Duysinx, B.; Corhay, J.L. 2007: Therapeutic update in respiratory medicine. Revue Medicale de Liege 62(5-6): 288-292

Lequerré, T.; Avenel, G.; Vittecoq, O. 2013: Therapeutic update in rheumatoid arthritis. La Revue de Medecine Interne 34(12): 754-762

Ruiz-Falcó Rojas, M.Luz. 2012: Therapeutic update in tuberous sclerosis complex: the role of mTOR pathway inhibitors. Revista de Neurologia 54 Suppl. 3: S19-S24

Sarnoff, D.S. 2014: Therapeutic update on Rosacea. Journal of Drugs in Dermatology: Jdd 13(1): 10-11

Rose, A.E. 2014: Therapeutic update on acne scarring. Journal of Drugs in Dermatology: Jdd 13(6): 651-654

Sarnoff, D.S. 2014: Therapeutic update on actinic keratosis. Journal of Drugs in Dermatology: Jdd 13(7): 785-786

Sarnoff, D.S. 2014: Therapeutic update on hyperhidrosis. Journal of Drugs in Dermatology: Jdd 13(8): 896-897

Stefanaki, I.; Katsambas, A. 2010: Therapeutic update on seborrheic dermatitis. Skin Therapy Letter 15(5): 1-4

Bordallo, M.Alice.Neves.; Ferreira, R.Martins.; Bulzico, D.Alves. 2011: Therapeutic update on the treatment of craniopharyngiomas. Arquivos Brasileiros de Endocrinologia e Metabologia 55(8): 520-527

Bowe, W.; Kober, M. 2014: Therapeutic update: acne. Journal of Drugs in Dermatology: Jdd 13(3): 235-238

Sarnoff, D.S. 2014: Therapeutic update: using lasers for tattoo removal. Journal of Drugs in Dermatology: Jdd 13(2): 108-109

Yan, N.; Zhang, S.; Yang, Y.; Cheng, L.; Li, C.; Dai, L.; Dai, L.; Zhang, X.; Fan, P.; Tian, H.; Wang, R.; Chen, X.; Su, X.; Li, Y.; Zhang, J.; Du, T.; Wei, Y.; Deng, H. 2012: Therapeutic upregulation of Class A scavenger receptor member 5 inhibits tumor growth and metastasis. Cancer Science 103(9): 1631-1639

Shabrang, C.; Kelbach, S.M.; Hsu, D.P.; Zippe, C.D.; Lie, K.T. 2012: Therapeutic ureteral occlusion with n-butyl cyanoacrylate glue and an AMPLATZER plug scaffold. Journal of Vascular and Interventional Radiology: Jvir 23(3): 428-430

Hernández-Pérez, F.; Herrera-Arellano, A. 2011: Therapeutic use Hibiscus sabadariffa extract in the treatment of hypercholesterolemia. a randomized clinical trial. Revista Medica del Instituto Mexicano del Seguro Social 49(5): 469-480

Ishikawa, M.; Yamada, Y. 2012: Therapeutic use and adverse events of incretin-related drugs. Nihon Rinsho. Japanese Journal of Clinical Medicine 70 Suppl. 3: 699-702

Fernández-Lobato, B.; Díaz-Carrasco, M.S.; Pareja, A.; Marín, M.; Vila, N.; de la Rubia, A. 2009: Therapeutic use and profile of toxicity of the FOLFOX4 regimen. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 33(2): 89-95

Fitch, K.D. 2013: Therapeutic use exemptions (TUEs) at the Olympic Games 1992-2012. British journal of sports medicine 47(13): 815-818

Machado Rocha, F.C.; Stéfano, S.C.; De Cássia Haiek, R.; Rosa Oliveira, L.M.Q.; Da Silveira, D.X. 2008: Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. European Journal of Cancer Care 17(5): 431-443

Park, S.; Yoon, J.; Bae, S.; Park, M.; Kang, C.; Ke, Q.; Lee, D.; Kang, P.M. 2014: Therapeutic use of H2O2-responsive anti-oxidant polymer nanoparticles for doxorubicin-induced cardiomyopathy. Biomaterials 35(22): 5944-5953

Tutar, Y. 2007: Therapeutic use of Heat Shock Protein 70. Recent Patents on Dna and Gene Sequences 1(2): 125-127

Wang, N.X.; Lee, H.-J.; Zheng, J.J. 2008: Therapeutic use of PDZ protein-protein interaction antagonism. Drug News and Perspectives 21(3): 137-141

Pagel, J.M.; Lionberger, J.; Gopal, A.K.; Sabath, D.E.; Loeb, K. 2007: Therapeutic use of Rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). American Journal of Hematology 82(12): 1121-1122

Verbsky, J.W. 2007: Therapeutic use of T regulatory cells. Current Opinion in Rheumatology 19(3): 252-258

Hostetter, S.J.; Helgerson, A.F.; Paton, J.C.; Paton, A.W.; Cornick, N.A. 2014: Therapeutic use of a receptor mimic probiotic reduces intestinal Shiga toxin levels in a piglet model of hemolytic uremic syndrome. Bmc Research Notes 7: 331

You, S.; Piali, L.; Kuhn, C.; Steiner, B.; Sauvaget, V.; Valette, F.; Clozel, M.; Bach, J.-F.ço.; Chatenoud, L. 2013: Therapeutic use of a selective S1P1 receptor modulator ponesimod in autoimmune diabetes. Plos one 8(10): E77296

Landreth, G. 2007: Therapeutic use of agonists of the nuclear receptor PPARgamma in Alzheimer's disease. Current Alzheimer research 4(2): 159-164

Sharc, S.E. 1949: Therapeutic use of albucid in suppurative ulcer of the cornea. Vestnik Oftalmologii 28(2): 28-30

Osawa, H.; Muraki, S.; Sakurada, T.; Kawaharada, N.; Sasaki, J.; Araki, E.; Nakashima, S. 2014: Therapeutic use of amiodarone against postoperative fibrillation after cardiac surgery. Kyobu Geka. Japanese Journal of Thoracic Surgery 67(5): 358-361

Sapin, V.; Souteyrand, G.; Bonnin, N.; Gallot, D.; Blanchon, L.; Chiambaretta, F. 2011: Therapeutic use of amniotic membranes and their derivate cells. Gynecologie Obstetrique and Fertilite 39(6): 388-390

Li, N.; Yang, Y. 2012: Therapeutic use of an anti-ErbB3 monoclonal antibody. Hybridoma 31(3): 149-154

Blank, C.U.; Enk, A. 2015: Therapeutic use of anti-CTLA-4 antibodies. International Immunology 27(1): 3-10

Khair, K.; Baker, K. 2008: Therapeutic use of arteriovenous fistula in children with haemophilia. British Journal of Nursing 17(22): 1396-1400

Whipple, K. 2007: Therapeutic use of assistive technology: a clinical perspective. Rehabilitation Nursing: the Official Journal of the Association of Rehabilitation Nurses 32(2): 48-50

Petronzelli, F.; Pelliccia, A.; Anastasi, A.M.; Lindstedt, R.; Manganello, S.; Ferrari, L.E.; Albertoni, C.; Leoni, B.; Rosi, A.; D'Alessio, V.; Deiana, K.; Paganelli, G.; De Santis, R. 2010: Therapeutic use of avidin is not hampered by antiavidin antibodies in humans. Cancer BioTherapy and Radiopharmaceuticals 25(5): 563-570

Ramachandran, R.; Yaksh, T.L. 2014: Therapeutic use of botulinum toxin in migraine: mechanisms of action. British Journal of Pharmacology 171(18): 4177-4192

Intiso, D. 2012: Therapeutic use of botulinum toxin in neurorehabilitation. Journal of Toxicology 2012: 802893

Lew, H.L.; Lee, E.H.; Castaneda, A.; Klima, R.; Date, E. 2008: Therapeutic use of botulinum toxin type a in treating neck and upper-back pain of myofascial origin: a pilot study. Archives of Physical Medicine and Rehabilitation 89(1): 75-80

Rodriguez, M.; Munoz-Castaneda, J.R.; Almaden, Y. 2014: Therapeutic use of calcitriol. Current Vascular Pharmacology 12(2): 294-299

De Vries, K.; Green, A.J. 2012: Therapeutic use of cannabis. Nursing Times 108(9): 12-15

Benyamina, A.; Reynaud, M. 2014: Therapeutic use of cannabis derivatives. La Revue du Praticien 64(2): 165-168

Villalba, J.M.; Parrado, C.; Santos-Gonzalez, M.; Alcain, F.J. 2010: Therapeutic use of coenzyme Q10 and coenzyme Q10-related compounds and formulations. Expert Opinion on Investigational Drugs 19(4): 535-554

Quinn, C.; Deegan, B.; Cooke, J.; Carew, S.; Hannigan, A.; Dunne, C.; Lyons, D. 2015: Therapeutic use of compression stockings for orthostatic hypotension: an assessment of patient and physician perspectives and practices. Age and Ageing 44(2): 339-342

Leger, L.H. 1947: Therapeutic use of concentrated proteins. Journal of the Kansas Medical Society 48(1): 12-15

Preobrazhenskii, A.P. 1950: Therapeutic use of corpus luteum hormone in gynecology. Novedades Medicas 16: 78-83

Webster, C.R.L.; Cooper, J. 2009: Therapeutic use of cytoprotective agents in canine and feline hepatobiliary disease. Veterinary Clinics of North America. Small Animal Practice 39(3): 631-652

Chen, L.; Fabian, K.L.; Taylor, J.L.; Storkus, W.J. 2013: Therapeutic use of dendritic cells to promote the extranodal priming of anti-tumor immunity. Frontiers in Immunology 4: 388

De Forest, I. 1948: Therapeutic use of depression. Journal of Clinical and Experimental Psychopathology 9(4): 574-578

Mitchell, G.; McCormack, B.; McCance, T. 2016: Therapeutic use of dolls for people living with dementia: A critical review of the literature. Dementia 15(5): 976-1001

Chapple, C. 2012: Therapeutic use of electrical stimulation of peripheral nerves to modulate lower urinary tract function and symptoms. Neurourology and Urodynamics 31(8): 1205

Satzger, I.; Schenck, F.; Thol, F.; Ganser, A.; Kapp, A.; Gutzmer, R. 2007: Therapeutic use of erythropoietin in dermatooncology. Journal der Deutschen Dermatologischen Gesellschaft 5(4): 280-285

Bauer, J.E. 2011: Therapeutic use of fish oils in companion animals. Journal of the American Veterinary Medical Association 239(11): 1441-1451

Cosler, L.E.; Eldar-Lissai, A.; Culakova, E.; Kuderer, N.M.; Dale, D.; Crawford, J.; Lyman, G.H. 2007: Therapeutic use of granulocyte colony-stimulating factors for established febrile neutropenia: effect on costs from a hospital perspective. Pharmacoeconomics 25(4): 343-351

Bachl, N.; Derman, W.; Engebretsen, L.; Goldspink, G.; Kinzlbauer, M.; Tschan, H.; Volpi, P.; Venter, D.; Wessner, B. 2009: Therapeutic use of growth factors in the musculoskeletal system in sports-related injuries. Journal of Sports Medicine and Physical Fitness 49(4): 346-357

Tutar, Y. 2010: Therapeutic use of heat shock proteins and essential factors in prognosis, diagnosis and treatment of neurodegenerative and metabolic diseases. Current Pharmaceutical Biotechnology 11(2): 138

Alvarez Bravo, A.; Castelazo Ayala, L.; Giménez Miranda, Mín.; Alvarez Bravo, A.; Castelazo Ayala, L.; Giménez Miranda, Mín. 2010: Therapeutic use of hormonal associations in Gynecology. 1955. Ginecologia y Obstetricia de Mexico 78(5): 291-306

Mizejewski, G.J. 2011: Therapeutic use of human alpha-fetoprotein in clinical patients: is a cancer risk involved?. International Journal of Cancer 128(1): 239-242

Stiehm, E.R.; Orange, J.S.; Ballow, M.; Lehman, H. 2010: Therapeutic use of immunoglobulins. Advances in Pediatrics 57(1): 185-218

Blackmore, T.K.; Manning, L.; Taylor, W.J.; Wallis, R.S. 2008: Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 47(10): E83-E85

Dentale, N.; Manfredi, R. 2007: Therapeutic use of interferons and their toxicity. Focus on peripheral neuropathy. Recenti Progressi in Medicina 98(6): 329-334

Chiaverini, R. 1948: Therapeutic use of lanatoside C. Hospital (Rio de Janeiro) 34(3): 405-431

Avunduk, A.M.; Tekelioglu, Y. 2006: Therapeutic use of limbal stem cells. Current Stem Cell Research and Therapy 1(2): 231-238

Fortunato, O.; Boeri, M.; Verri, C.; Moro, M.; Sozzi, G. 2014: Therapeutic use of micro RNAs in lung cancer. Biomed Research International 2014: 756975

Eyles, J.E. 2007: Therapeutic use of molecules that mimic pathogen danger signals. Endocrine Metabolic and Immune Disorders Drug Targets 7(3): 177-186

Luke, T.D.; Luke, T.D. 2012: Therapeutic use of mud. 1912. Practitioner 256(1751): 28

Winblad, B.; Fioravanti, M.; Dolezal, T.; Logina, I.; Milanov, I.G.; Popescu, D.C.; Solomon, A. 2008: Therapeutic use of nicergoline. Clinical Drug Investigation 28(9): 533-552

Holmes, H.R.; Vlaisavljevich, E.; Tan, E.L.; Snyder, K.L.; Ong, K.G.; Rajachar, R.M. 2018: Control of cellular adhesion and myofibroblastic character with sub-micrometer magnetoelastic vibrations. Journal of Biomechanics 71: 199-207

Balanzá-Martínez, V.; Fries, G.R.; Colpo, G.D.; Silveira, P.P.; Portella, A.é K.; Tabarés-Seisdedos, R.; Kapczinski, F.áv. 2011: Therapeutic use of omega-3 fatty acids in bipolar disorder. Expert Review of Neurotherapeutics 11(7): 1029-1047

Ozono, K.; Hasegawa, Y.; Minagawa, M.; Adachi, M.; Namba, N.; Kazukawa, I.; Kitaoka, T.; Asakura, Y.; Shimura, A.; Naito, Y. 2014: Therapeutic use of oral sodium phosphate (phosribbon(®) combination granules) in hereditary hypophosphatemic rickets. Clinical Pediatric Endocrinology: Case Reports and Clinical Investigations: Official Journal of the Japanese Society for Pediatric Endocrinology 23(1): 9-15

Taumi, A. 1949: Therapeutic use of penicillin in ophthalmia neonatorum. Vestnik Oftalmologii 28(2): 19

Kharchenko, N.S. 1947: Therapeutic use of placenta. Akusherstvo i Ginekologiia 10(2): 27-31

Lazić, Z.; Bubalo, M.; Petković-Curcin, A.; Dukat, M.; Mihajlović, B. 2009: Therapeutic use of platelet-rich plasma in oral surgery. Vojnosanitetski Pregled 66(10): 821-825

Patel, R.Mangal.; Denning, P.Wei. 2013: Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence?. Clinics in Perinatology 40(1): 11-25

Vatier, C.; Gautier, J.-F.ço.; Vigouroux, C. 2012: Therapeutic use of recombinant methionyl human leptin. Biochimie 94(10): 2116-2125

Langer, S.Z. 2008: Therapeutic use of release-modifying drugs. Handbook of Experimental Pharmacology 184: 561-573

Taylor, R.R.; Lee, S.W.; Kielhofner, G.; Ketkar, M. 2009: Therapeutic use of self: a nationwide survey of practitioners' attitudes and experiences. American Journal of Occupational Therapy: Official Publication of the American Occupational Therapy Association 63(2): 198-207

Mizuguchi, Y.; Yokomuro, S.; Mishima, T.; Arima, Y.; Shimizu, T.; Kawahigashi, Y.; Takizawa, T.; Tajiri, T. 2007: Therapeutic use of short hairpin RNA in acute liver failure. Journal of Nippon Medical School 74(1): 74-76

Zheng, S.-J.; Chen, P.; Duan, Z.-P. 2009: Therapeutic use of small interfering RNA in acute liver failure animal model. Zhonghua Gan Zang Bing Za Zhi 17(3): 238-240

Ward, W.E. 1946: Therapeutic use of specific typhoid bacteriophage. Journal of Bacteriology 51: 619

Choi, M.; Ban, T.; Rhim, T. 2014: Therapeutic use of stem cell transplantation for cell replacement or cytoprotective effect of microvesicle released from mesenchymal stem cell. Molecules and Cells 37(2): 133-139

Knipper, M. 2007: Therapeutic use of stem cells. Hno 55(11): 845-847

Naidoo, R.J.; Williams, H.C. 2013: Therapeutic use of stories for children with atopic eczema and other chronic skin conditions. Pediatric Dermatology 30(6): 765-767

Erpenbeck, V.J.; Krug, N.; Hohlfeld, J.M. 2009: Therapeutic use of surfactant components in allergic asthma. Naunyn-Schmiedeberg's Archives of Pharmacology 379(3): 217-224

Mancuso, C.; Barone, E. 2009: Therapeutic use of tea derivatives: all that glitters is not gold. Blood 114(11): 2359-2360

Freed, S.C. 1946: Therapeutic use of testosterone in aqueous suspension. Journal of Clinical Endocrinology and Metabolism 6: 571-574

López Del Val, L.J.; López-García, E.; Martínez-Martínez, L.; Santos-Lasaosa, S. 2009: Therapeutic use of tetrabenazine. Revista de Neurologia 48(10): 523-533

Tyagi, P.; Jain, V.K.; Nadler, E. 2005: Therapeutic use of the cannabinoid receptor antagonist rimonabant in weight loss and smoking cessation. Supportive Cancer Therapy 3(1): 11-13

Barton Pai, A.; Conner, T.A.; McQuade, C.R. 2009: Therapeutic use of the phosphate binder lanthanum carbonate. Expert Opinion on Drug Metabolism and Toxicology 5(1): 71-81

Kaya, T.I.; Tursen, U.; Ikizoglu, G. 2009: Therapeutic use of topical corticosteroids in the vesiculobullous lesions of incontinentia pigmenti. Clinical and Experimental Dermatology 34(8): E611-E613

Manchikanti, L.; Fellows, B.; Ailinani, H.; Pampati, V. 2010: Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician 13(5): 401-435

Nakayama, T.; Noguchi, S. 2010: Therapeutic usefulness of postoperative adjuvant chemotherapy with Tegafur-Uracil (UFT) in patients with breast cancer: focus on the results of clinical studies in Japan. Oncologist 15(1): 26-36

Mikaili, P.; Maadirad, S.; Moloudizargari, M.; Aghajanshakeri, S.; Sarahroodi, S. 2013: Therapeutic uses and pharmacological properties of garlic, shallot, and their biologically active compounds. Iranian Journal of Basic Medical Sciences 16(10): 1031-1048

Grace, O.M.; Simmonds, M.S.J.; Smith, G.F.; van Wyk, A.E. 2008: Therapeutic uses of Aloe L. (Asphodelaceae) in southern Africa. Journal of Ethnopharmacology 119(3): 604-614

Cattell, M.; Chenoweth, M.B. 1948: Therapeutic uses of BAL. New York State Journal of Medicine 48(6): 643-650

Gupta, R.K.; Lakshmi, V.; Mahapatra, S.; Jha, C.B. 2010: Therapeutic uses of Swarnamakshika Bhasma (A Critical Review). Ayu 31(1): 106-110

Wang, D.Q.-H.; Carey, M.C. 2014: Therapeutic uses of animal biles in traditional Chinese medicine: an ethnopharmacological, biophysical chemical and medicinal review. World Journal of Gastroenterology 20(29): 9952-9975

Philips, G.K.; Atkins, M. 2015: Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies. International Immunology 27(1): 39-46

Kang, S.; Tanaka, T.; Kishimoto, T. 2015: Therapeutic uses of anti-interleukin-6 receptor antibody. International Immunology 27(1): 21-29

Schwab, N.; Schneider-Hohendorf, T.; Wiendl, H. 2015: Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis. International Immunology 27(1): 47-53

De Ronde, W. 2007: Therapeutic uses of aromatase inhibitors in men. Current Opinion in Endocrinology Diabetes and Obesity 14(3): 235-240

De Maio, M.íc. 2008: Therapeutic uses of botulinum toxin: from facial palsy to autonomic disorders. Expert Opinion on Biological Therapy 8(6): 791-798

Babizhayev, M.A.; Yegorov, Y.E. 2010: Therapeutic uses of drug-carrier systems for imidazole-containing dipeptide compounds that act as pharmacological chaperones and have significant impact on the treatment of chronic diseases associated with increased oxidative stress and the formation of advanced glycation end products. Critical Reviews in Therapeutic Drug Carrier Systems 27(2): 85-154

Tompsett, R.; Yankauer, A. 1948: Therapeutic uses of gamma globulin. American Journal of Medicine 5(4): 590-598

Goldim, J.é R. 2008: Therapeutic uses of investigational drugs: research extension, compassionate use, and expanded access. Revista Panamericana de Salud Publica 23(3): 198-206

Anrep, G.V.; Barsoum, G.S. 1947: Therapeutic uses of khellin; method of standardisation. Lancet 1(6452): 557

Guerrera, M.P.; Volpe, S.L.; Mao, J.J. 2009: Therapeutic uses of magnesium. American Family Physician 80(2): 157-162

López Herranz, M.; Bas Caro, P.; Carabantes Alarcón, D.; Padín Galea, J.é M. 2011: Therapeutic uses of ortho-podiatry in the diabetic foot. Revista de Enfermeria 34(10): 30-39

Shimshelevich, B.J. 1945: Therapeutic uses of paraffin and sand. Meditsinskaia Sestra 1945(7-8): 23-27

Graubard, D.J.; Peterson, M.C. 1949: Therapeutic uses of procaine administered intravenously. Connecticut State Medical Journal 13(11): 1021-1027

Quimby, E.H. 1950: Therapeutic uses of radioisotopes. New York Journal of Dentistry 20(8-9): 301-302

Chlebowski, S.; Fremont, W. 2011: Therapeutic uses of the WebCam in child psychiatry. Academic Psychiatry: the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 35(4): 263-267

Luthra, P.M.; Singh, R.; Chandra, R. 2001: Therapeutic uses of Curcuma longa (turmeric). Indian Journal of Clinical Biochemistry: Ijcb 16(2): 153-160

Wu, X.; Li, Y. 2011: Therapeutic utilities of fibroblast growth factor 19. Expert Opinion on Therapeutic Targets 15(11): 1307-1316

Han, S.; Thatte, J.; Buzard, D.J.; Jones, R.M. 2013: Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists. Journal of Medicinal Chemistry 56(21): 8224-8256

Kehne, J.H.; Cain, C.K. 2010: Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal models. Pharmacology and Therapeutics 128(3): 460-487

Hesselink, J.M.K.; Hekker, T.A. 2012: Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series. Journal of Pain Research 5: 437-442

Medina, A.E. 2011: Therapeutic utility of phosphodiesterase type i inhibitors in neurological conditions. Frontiers in Neuroscience 5: 21

Ward, D.P. 1949: Therapeutic utilization of the physiological reserves. Nebraska State Medical Journal 34(1): 27-29

Berge, G.; Eliassen, L.T.; Camilio, K.A.; Bartnes, K.; Sveinbjørnsson, B.; Rekdal, O. 2010: Therapeutic vaccination against a murine lymphoma by intratumoral injection of a cationic anticancer peptide. Cancer Immunology Immunotherapy: Cii 59(8): 1285-1294

Femel, J.; Huijbers, E.J.M.; Saupe, F.; Cedervall, J.; Zhang, L.; Roswall, P.; Larsson, E.; Olofsson, H.; Pietras, K.; Dimberg, A.; Hellman, L.; Olsson, A.-K. 2014: Therapeutic vaccination against fibronectin ED-A attenuates progression of metastatic breast cancer. Oncotarget 5(23): 12418-12427

Van der Burg, S.H.; Melief, C.J.M. 2011: Therapeutic vaccination against human papilloma virus induced malignancies. Current Opinion in Immunology 23(2): 252-257

Shanley, C.A.; Ireton, G.C.; Baldwin, S.L.; Coler, R.N.; Reed, S.G.; Basaraba, R.J.; Orme, I.M. 2014: Therapeutic vaccination against relevant high virulence clinical isolates of Mycobacterium tuberculosis. Tuberculosis 94(2): 140-147

Silveira, E.L.V.; Fogg, M.H.; Leskowitz, R.M.; Ertl, H.C.; Wiseman, R.W.; O'Connor, D.H.; Lieberman, P.; Wang, F.; Villinger, F. 2013: Therapeutic vaccination against the rhesus lymphocryptovirus EBNA-1 homologue, rhEBNA-1, elicits T cell responses to novel epitopes in rhesus macaques. Journal of Virology 87(24): 13904-13910

Bertoletti, A.; Gehring, A. 2009: Therapeutic vaccination and novel strategies to treat chronic HBV infection. Expert Review of Gastroenterology and Hepatology 3(5): 561-569

Geldmacher, A.; Freier, A.; Losch, F.O.; Walden, P. 2011: Therapeutic vaccination for cancer immunotherapy: antigen selection and clinical responses. Human Vaccines 7 Suppl: 115-119

Ferrari, C. 2008: Therapeutic vaccination for hepatitis C: can protective T-cell responses be restored after prolonged antigen exposure?. Gastroenterology 134(5): 1601-1604

Ding, M.; Yang, J. 2014: Therapeutic vaccination for non-small-cell lung cancer: a meta-analysis. Medical Oncology 31(4): 928

Walden, P. 2007: Therapeutic vaccination for the treatment of malignant melanoma. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 176: 219-227

Kosinska, A.D.; Zhang, E.; Lu, M.; Roggendorf, M. 2010: Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck. Hepatitis Research and Treatment 2010: 817580

Krawczyk, A.; Roggendorf, H.; Ludwig, C.; Herzer, K.; Gerken, G.; Horn, P.A.; Roggendorf, M.; Lindemann, M. 2013: Therapeutic vaccination of a liver transplant recipient suffering from fulminant hepatitis B during pregnancy. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 19(12): 1411-1412

Olsson, A.-K. 2014: Therapeutic vaccination targeting the tumour vasculature. Biochemical Society Transactions 42(6): 1653-1657

Boukhebza, H.; Bellon, N.; Limacher, J.M.; Inchauspé, G.èv. 2012: Therapeutic vaccination to treat chronic infectious diseases: current clinical developments using MVA-based vaccines. Human Vaccines and Immunotherapeutics 8(12): 1746-1757

Román, V.R.úl.G.óm.; Jensen, K.J.; Jensen, S.S.; Leo-Hansen, C.; Jespersen, S.; da Silva Té, D.; Rodrigues, C.M.; Janitzek, C.M.; Vinner, L.; Katzenstein, T.L.; Andersen, P.; Kromann, I.; Andreasen, L.V.; Karlsson, I.; Fomsgaard, A. 2013: Therapeutic vaccination using cationic liposome-adjuvanted HIV type 1 peptides representing HLA-supertype-restricted subdominant T cell epitopes: safety, immunogenicity, and feasibility in Guinea-Bissau. Aids Research and Human Retroviruses 29(11): 1504-1512

Quoix, E.; Ramlau, R.; Westeel, V.; Papai, Z.; Madroszyk, A.; Riviere, A.; Koralewski, P.; Breton, J-Luc.; Stoelben, E.; Braun, D.; Debieuvre, D.; Lena, Hé.; Buyse, M.; Chenard, M-Pierre.; Acres, B.; Lacoste, Gèle.; Bastien, Bérangère.; Tavernaro, A.; Bizouarne, N.; Bonnefoy, J-Yves.; Limacher, J-Marc. 2011: Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial. Lancet. Oncology 12(12): 1125-1133

Rodriguez, G.; Gonzalez, G.; Crombet, T.; Lage, A. 2011: Therapeutic vaccination with an EGF-based vaccine in lung cancer: a step in the transition to a chronic disease. Expert Review of Respiratory Medicine 5(3): 337-342

Wilgenhof, S.; Van Nuffel, A.M.T.; Corthals, J.; Heirman, C.; Tuyaerts, S.; Benteyn, D.é; De Coninck, A.; Van Riet, I.; Verfaillie, G.; Vandeloo, J.; Bonehill, A.; Thielemans, K.; Neyns, B. 2011: Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma. Journal of ImmunoTherapy 34(5): 448-456

Brill, T.H.; Kübler, H.R.; Pohla, H.; Buchner, A.; Fend, F.; Schuster, T.; van Randenborgh, H.; Paul, R.; Kummer, T.; Plank, C.; Eisele, B.; Breul, J.ür.; Hartung, R.; Schendel, D.J.; Gansbacher, B. 2009: Therapeutic vaccination with an interleukin-2-interferon-gamma-secreting allogeneic tumor vaccine in patients with progressive castration-resistant prostate cancer: a phase I/Ii trial. Human Gene Therapy 20(12): 1641-1651

Toomey, D.; Conroy, H.; Jarnicki, A.G.; Higgins, S.C.; Sutton, C.; Mills, K.H.G. 2008: Therapeutic vaccination with dendritic cells pulsed with tumor-derived Hsp70 and a COX-2 inhibitor induces protective immunity against B16 melanoma. Vaccine 26(27-28): 3540-3549

Maroof, A.; Brown, N.; Smith, B.; Hodgkinson, M.R.; Maxwell, A.; Losch, F.O.; Fritz, U.; Walden, P.; Lacey, C.N.J.; Smith, D.F.; Aebischer, T.; Kaye, P.M. 2012: Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasis. Journal of Infectious Diseases 205(5): 853-863

Halwani, R.; Boyer, J.D.; Yassine-Diab, B.; Haddad, E.K.; Robinson, T.M.; Kumar, S.; Parkinson, R.; Wu, L.; Sidhu, M.K.; Phillipson-Weiner, R.; Pavlakis, G.N.; Felber, B.K.; Lewis, M.G.; Shen, A.; Siliciano, R.F.; Weiner, D.B.; Sekaly, R-Pierre. 2008: Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA + IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaques. Journal of Immunology 180(12): 7969-7979

McMurray, D.N. 2013: Therapeutic vaccination: hope for untreatable tuberculosis?. Journal of Infectious Diseases 207(8): 1193-1194

Wedemeyer, H.; Schuller, E.; Schlaphoff, V.; Stauber, R.E.; Wiegand, J.; Schiefke, I.; Firbas, C.; Jilma, B.; Thursz, M.; Zeuzem, S.; Hofmann, W.P.; Hinrichsen, H.; Tauber, E.; Manns, M.P.; Klade, C.S. 2009: Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C. Vaccine 27(37): 5142-5151

Pang, Z.; Nakagami, H.; Osako, M.K.; Koriyama, H.; Nakagami, F.; Tomioka, H.; Shimamura, M.; Kurinami, H.; Takami, Y.; Morishita, R.; Rakugi, H. 2014: Therapeutic vaccine against DPP4 improves glucose metabolism in mice. Proceedings of the National Academy of Sciences of the United States of America 111(13): E1256-E1263

Keeble, J.R.; Walker, K.B. 2009: Therapeutic vaccine comprising Mycobacterium HSP70. Expert Opinion on Therapeutic Patents 19(1): 95-99

Carlson, B. 2011: Therapeutic vaccine for brain cancer succeeds using a unique approach. Biotechnology Healthcare 8(3): 31-32

Ding, Z.; Wei, Y. 2007: Therapeutic vaccine for melanoma: the untouched grail?. Expert Review of Vaccines 6(6): 907-911

Riedmann, E.M. 2012: Therapeutic vaccine for treatment of genital herpes enters phase 2. Human Vaccines and Immunotherapeutics 8(12): 1744

García, F.; León, A.; Gatell, J.M.; Plana, M.; Gallart, T. 2012: Therapeutic vaccines against HIV infection. Human Vaccines and Immunotherapeutics 8(5): 569-581

Hellman, L. 2008: Therapeutic vaccines against IgE-mediated allergies. Expert Review of Vaccines 7(2): 193-208

Kiessling, R.; Ljungberg, K.; Von Gabain, A. 2008: Therapeutic vaccines against cancer and infectious diseases. Great possibilities in the research--small clinical progress so far. Lakartidningen 105(36): 2402-2404

Xue, J.; Zhu, H.; Chen, Z. 2014: Therapeutic vaccines against hepatitis C virus. Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 22: 120-129

Qiu, Z.; Chen, X.; Zhou, Y.; Lin, J.; Ding, D.; Yang, S.; Chen, F.; Wang, M.; Zhu, F.; Yu, X.; Zhou, Z.; Liao, Y. 2013: Therapeutic vaccines against human and rat renin in spontaneously hypertensive rats. Plos one 8(6): E66420

Cid-Arregui, A. 2009: Therapeutic vaccines against human papillomavirus and cervical cancer. Open Virology Journal 3: 67-83

Fahim, R.E.F.; Kessler, P.D.; Kalnik, M.W. 2013: Therapeutic vaccines against tobacco addiction. Expert Review of Vaccines 12(3): 333-342

Cardona, P.-J. 2007: Therapeutic vaccines against tuberculosis: a glowing future. Archivos de Bronconeumologia 43(11): 591-593

Karkada, M.; Berinstein, N.L.; Mansour, M. 2014: Therapeutic vaccines and cancer: focus on DPX-0907. Biologics: Targets and Therapy 8: 27-38

Michel, M-Louise.; Deng, Q.; Mancini-Bourgine, M. 2011: Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges. Journal of Hepatology 54(6): 1286-1296

Oviedo-Orta, E.; Plotkin, S.A.; Ulmer, J.B.; Ahmed, S.S. 2013: Therapeutic vaccines and immunotherapies: current challenges and new frontiers. Expert Review of Vaccines 12(3): 243-244

Gulley, J.L.; Madan, R.A.; Heery, C.R. 2013: Therapeutic vaccines and immunotherapy in castration-resistant prostate cancer: current progress and clinical applications. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting 2013

Singh, B.H.; Gulley, J.L. 2014: Therapeutic vaccines as a promising treatment modality against prostate cancer: rationale and recent advances. Therapeutic Advances in Vaccines 2(5): 137-148

Chorobik, P.; Marcinkiewicz, J. 2011: Therapeutic vaccines based on genetically modified Salmonella: a novel strategy in cancer immunotherapy. Polskie Archiwum Medycyny Wewnetrznej 121(12): 461-466

Ma, K.; Tang, Y.H. 2014: Therapeutic vaccines explored in patients with non-small cell lung cancer. Anti-Cancer Agents in Medicinal Chemistry 14(2): 256-264

Fiander, A.; Man, S.; Borysiewicz, L.K.; Wilkinson, G.W. 1997: Therapeutic vaccines for cervical cancer: concept and clinical results. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 8(5): 331-338

Bachmann, M.F.; Jennings, G.T. 2011: Therapeutic vaccines for chronic diseases: successes and technical challenges. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 366(1579): 2815-2822

Rahma, O.E.; Khleif, S.N. 2011: Therapeutic vaccines for gastrointestinal cancers. Gastroenterology and Hepatology 7(8): 517-564

Nakagami, H.; Koriyama, H.; Morishita, R. 2014: Therapeutic vaccines for hypertension and dyslipidemia. International Heart Journal 55(2): 96-100

Khamesipour, A. 2014: Therapeutic vaccines for leishmaniasis. Expert Opinion on Biological Therapy 14(11): 1641-1649

Gustafson, M.P.; Knutson, K.L.; Dietz, A.B. 2008: Therapeutic vaccines for malignant brain tumors. Biologics: Targets and Therapy 2(4): 753-761

Briones, J. 2008: Therapeutic vaccines for non-Hodgkin B-cell lymphoma. Clinical and Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 10(9): 543-551

Liao, J.B.; Disis, M.L. 2013: Therapeutic vaccines for ovarian cancer. Gynecologic Oncology 130(3): 667-673

Cha, E.; Fong, L. 2010: Therapeutic vaccines for prostate cancer. Current Opinion in Molecular Therapeutics 12(1): 77-85

Gröschel, M.I.; Prabowo, S.A.; Cardona, P.èr.-J.; Stanford, J.L.; van der Werf, T.S. 2014: Therapeutic vaccines for tuberculosis--a systematic review. Vaccine 32(26): 3162-3168

Van der Burg, S.H. 2008: Therapeutic vaccines in cancer: moving from immunomonitoring to immunoguiding. Expert Review of Vaccines 7(1): 1-5

Madan, R.A.; Mohebtash, M.; Schlom, J.; Gulley, J.L. 2010: Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design. Expert Opinion on Biological Therapy 10(1): 19-28

Schwaab, T.; Ernstoff, M.S. 2011: Therapeutic vaccines in renal cell carcinoma. Therapy 4(8): 369-377

Eggermont, A.M.M. 2009: Therapeutic vaccines in solid tumours: can they be harmful?. European Journal of Cancer 45(12): 2087-2090

Mosalanejad, L.; Abdolahifard, K.; Jahromi, M.G. 2013: Therapeutic vaccines: hope therapy and its effects on psychiatric symptoms among infertile women. Global Journal of Health Science 6(1): 192-200

Gulley, J.L. 2013: Therapeutic vaccines: the ultimate personalized therapy?. Human Vaccines and Immunotherapeutics 9(1): 219-221

Hoogeboom, T.J.; Oosting, E.; Vriezekolk, J.E.; Veenhof, C.; Siemonsma, P.C.; de Bie, R.A.; van den Ende, C.H.M.; van Meeteren, N.L.U. 2012: Therapeutic validity and effectiveness of preoperative exercise on functional recovery after joint replacement: a systematic review and meta-analysis. Plos one 7(5): E38031

Jayasundara, J.A.S.B.; de Silva, W.M.M.; Pathirana, A.A. 2010: Therapeutic value and outcome of gastric access loops created during hepaticojejunostomy for iatrogenic bile duct injuries. Surgeon: Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland 8(6): 325-329

Mates, J. 1948: Therapeutic value of Mariánké Láznĕ. Casopis Lekaru Ceskych 87(27-28): 812-816

Gunawardana, S.C. 2012: Therapeutic value of brown adipose tissue: Correcting metabolic disease through generating healthy fat. Adipocyte 1(4): 250-255

Schujman, S. 1947: Therapeutic value of chaulmoogra in the treatment of leprosy. International Journal of Leprosy 15(2): 135-145

Hagag, A.A.; Elfrargy, M.S.; Gazar, R.A.; El-Lateef, A.E.A. 2013: Therapeutic value of combined therapy with deferasirox and silymarin on iron overload in children with Beta thalassemia. Mediterranean Journal of Hematology and Infectious Diseases 5(1): E2013065

Li, Q-lin.; Zhong, Y-shi.; Zhou, P-hong.; Xu, M-dong.; Zhang, Y-qun.; Chen, W-feng.; Ma, L-li.; Qin, W-zheng.; Yao, L-qing. 2012: Therapeutic value of endoscopic submucosal dissection for gastrointestinal stromal tumor in the esophagogastric junction. Zhonghua Wei Chang Wai Ke Za Zhi 15(3): 236-239

Webb, S.M. 2008: Therapeutic value of growth hormone. Medicina Clinica 130(7): 261-262

Withrow, D.R.; DeGroot, J.M.; Siemens, D.Robert.; Groome, P.A. 2011: Therapeutic value of lymph node dissection at radical prostatectomy: a population-based case-cohort study. Bju International 108(2): 209-216

Shimada, K.; Sano, T.; Nara, S.; Esaki, M.; Sakamoto, Y.; Kosuge, T.; Ojima, H. 2009: Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery 145(4): 411-416

Tokunaga, M.; Ohyama, S.; Hiki, N.; Fukunaga, T.; Inoue, H.; Yamada, K.; Sano, T.; Yamaguchi, T.; Nakajima, T. 2009: Therapeutic value of lymph node dissection in advanced gastric cancer with macroscopic duodenum invasion: is the posterior pancreatic head lymph node dissection beneficial?. Annals of Surgical Oncology 16(5): 1241-1246

Maillard, H.; Fenot, M.; Bara, C.; Célérier, P. 2011: Therapeutic value of moderate-dose oxybutynin in extensive hyperhidrosis. Annales de Dermatologie et de Venereologie 138(10): 652-656

Lapanashvili, L.V.; Buziashvili, Y.I.; Matskeplishvili, S.T.; Lobjanidze, T.G.; Yoshina, V.I.; Kamardinov, D.K.; Tugeeva, E.F.; Bockeria, L.A. 2009: Therapeutic value of muscular counterpulsation after coronary bypass grafting operation. Journal of Cardiac Surgery 24(2): 134-140

Bilbro, J.; Mart, M.; Kyprianou, N. 2013: Therapeutic value of quinazoline-based compounds in prostate cancer. Anticancer Research 33(11): 4695-4700

Ji, Z.-L.; Li, J.-S.; Yuan, C.-W.; Chen, W.-d.; Zhang, Y.-N.; Ju, X.-T.; Tang, W.-H. 2010: Therapeutic value of sesame oil in the treatment of adhesive small bowel obstruction. American Journal of Surgery 199(2): 160-165

Tan, X.; Xie, P.; Liu, J.; Wu, H.; Xie, Y. 2015: Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: a pilot study. Asia-Pacific Journal of Clinical Oncology 11(3): E6

Patel, A.; Mamtani, M.; Dibley, M.J.; Badhoniya, N.; Kulkarni, H. 2010: Therapeutic value of zinc supplementation in acute and persistent diarrhea: a systematic review. Plos one 5(4): E10386

Pelc, Z. 2002: Therapeutic values of dance movement and its influence on psychomotor development of deaf persons as a form of socialization and integration with the environment. Wiadomosci Lekarskie 55 Suppl 1(Part 2): 845-849

Takagi, G.; Miyamoto, M.; Tara, S.; Kirinoki-Ichikawa, S.; Kubota, Y.; Hada, T.; Takagi, I.; Mizuno, K. 2014: Therapeutic vascular angiogenesis for intractable macroangiopathy-related digital ulcer in patients with systemic sclerosis: a pilot study. Rheumatology 53(5): 854-859

Nobari, S.; Mongrain, R.; Gaillard, E.; Leask, R.; Cartier, R. 2012: Therapeutic vascular compliance change may cause significant variation in coronary perfusion: a numerical study. Computational and Mathematical Methods in Medicine 2012: 791686

Loffredo, F.; Lee, R.T. 2008: Therapeutic vasculogenesis: it takes two. Circulation Research 103(2): 128-130

Minami, S.S.; Sidahmed, E.; Aid, S.; Shimoji, M.; Niikura, T.; Mocchetti, I.; Rebeck, G.W.; Prendergast, J.S.; Dealwis, C.; Wetzel, R.; Bosetti, F.; Matsuoka, Y.; Hoe, H.-S.; Turner, R.S. 2010: Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease. Journal of Neuroinflammation 7: 57

Steel, K.; Cox, D.; Garry, H. 2011: Therapeutic videoconferencing interventions for the treatment of long-term conditions. Journal of Telemedicine and Telecare 17(3): 109-117

Rozenbaum, M.; Slobodin, G.; Boulman, N.; Feld, J.; Avshovich, N.; Ben-Arieh, Y.; Rosner, I. 2008: Therapeutic vignette: old and new drugs in mixed connective tissue disease. Israel Medical Association Journal: Imaj 10(11): 831-832

Vistica, D.T.; Hollingshead, M.; Borgel, S.D.; Kenney, S.; Stockwin, L.H.; Raffeld, M.; Schrump, D.S.; Burkett, S.; Stone, G.; Butcher, D.O.; Shoemaker, R.H. 2009: Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy. Journal of Pediatric Hematology/Oncology 31(8): 561-570

Morgan, C.; Bingham, D.; Holt, D.C.B.; Jones, D.M.; Lewis, N.J. 2010: Therapeutic whole lung lavage for inhaled plutonium oxide revisited. Journal of Radiological Protection: Official Journal of the Society for Radiological Protection 30(4): 735-746

Sullivan, P.G.; Sebastian, A.H.; Hall, E.D. 2011: Therapeutic window analysis of the neuroprotective effects of cyclosporine a after traumatic brain injury. Journal of Neurotrauma 28(2): 311-318

Wojnicz, R.; Nowak, J.; Lekston, A.; Wilczewski, P.ła.; Nowalany-Kozielska, E.; Streb, W.; Wojciechowska, C.; Stolarz, W.; Helewski, K.; Szyguła-Jurkiewicz, B.że.; Poloński, L. 2010: Therapeutic window for calcium-channel blockers in the management of dilated cardiomyopathy: a prospective, two-centre study on non-advanced disease. Cardiology 117(2): 148-154

Fetoni, A.R.; Eramo, S.; Troiani, D.; Paludetti, G. 2011: Therapeutic window for ferulic acid protection against noise-induced hearing loss in the guinea pig. Acta Oto-Laryngologica 131(4): 419-427

Lapchak, P.A.; Kirkeby, A.; Zivin, J.A.; Sager, T.N. 2008: Therapeutic window for nonerythropoietic carbamylated-erythropoietin to improve motor function following multiple infarct ischemic strokes in New Zealand white rabbits. Brain Research 1238: 208-214

Uchida, H.; Suzuki, T.; Graff-Guerrero, A.; Mulsant, B.H.; Pollock, B.G.; Arenovich, T.; Rajji, T.K.; Mamo, D.C. 2014: Therapeutic window for striatal dopamine D(2/3) receptor occupancy in older patients with schizophrenia: a pilot PET study. American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry 22(10): 1007-1016

Uzun, G.; Yildiz, S. 2008: Therapeutic window for the use of hyperbaric oxygen therapy in idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx 35(2): 318; Author Reply 319

De Vasconcelos Dos Santos, A.éi.; da Costa Reis, J.; Diaz Paredes, B.; Moraes, L.; Jasmin; Giraldi-Guimarães, A.; Mendez-Otero, R. 2010: Therapeutic window for treatment of cortical ischemia with bone marrow-derived cells in rats. Brain Research 1306: 149-158

Amann, M.; Friedrich, M.; Lutterbuese, P.; Vieser, E.; Lorenczewski, G.; Petersen, L.; Brischwein, K.; Kufer, P.; Kischel, R.; Baeuerle, P.A.; Schlereth, B. 2009: Therapeutic window of an EpCAM/CD3-specific BiTE antibody in mice is determined by a subpopulation of EpCAM-expressing lymphocytes that is absent in humans. Cancer Immunology Immunotherapy: Cii 58(1): 95-109

Wang, X.-L.; Zhao, Y.-S.; Yang, Y.-J.; Xie, M.; Yu, X.-H. 2008: Therapeutic window of hyperbaric oxygen therapy for hypoxic-ischemic brain damage in newborn rats. Brain Research 1222: 87-94

Langer, M.; Brandt, C.; Zellinger, C.; Löscher, W. 2011: Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats. Neuropharmacology 61(5-6): 1033-1047

Sramek, C.K.; Leung, L.-S.B.; Paulus, Y.M.; Palanker, D.V. 2012: Therapeutic window of retinal photocoagulation with green (532-nm) and yellow (577-nm) lasers. Ophthalmic Surgery Lasers and Imaging: the Official Journal of the International Society for Imaging in the Eye 43(4): 341-347

Liang, Y-Min.; Jiang, J-Yao.; Mao, Q.; Zhang, S.; Xu, W. 2009: Therapeutic window of selective profound cerebral hypothermia for resuscitation of severe cerebral ischemia in primates. Journal of Neurotrauma 26(11): 2107-2112

Sun, M.; Zhao, Y.-M.; Gu, Y.; Xu, C. 2012: Therapeutic window of taurine against experimental stroke in rats. Translational Research: the Journal of Laboratory and Clinical Medicine 160(3): 223-229

Li, S.C.; Han, Y.-P.; Dethlefs, B.A.; Loudon, W.G. 2010: Therapeutic window, a critical developmental stage for stem cell therapies. Current Stem Cell Research and Therapy 5(4): 297

Anonymous 2010: Therapeutic windows. Molecular Interventions 10(2): 69-71

Goldkorn, A.; Aparicio, A.M.; Quinn, D.I. 2013: Therapeutic windows and opportunity cost cast upon prostate cancer's fatal shore. Annals of Oncology: Official Journal of the European Society for Medical Oncology 24(7): 1717-1720

Jiang, W.-Y. 2005: Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. Discovery Medicine 5(29): 455-461

Hoffman, M.E. 1945: Therapeutic work of local voluntary units in tuberculosis. Problemy Tuberkuleza 3: 77

Shiller, V.M. 2008: Therapeutic work with a physically abused preschooler. Psychoanalytic Study of the Child 63: 83-110

Kondratyuk, N.; Perakyla, A. 2011: Therapeutic work with the present moment: a comparative conversation analysis of existential and cognitive therapies. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 21(3): 316-330

Ravikiran, S.P.; Sacchidanand, S.; Leelavathy, B. 2014: Therapeutic wounding - 88% phenol in idiopathic guttate hypomelanosis. Indian Dermatology Online Journal 5(1): 14-18

Furnes, B.; Dysvik, E. 2012: Therapeutic writing and chronic pain: experiences of therapeutic writing in a cognitive behavioural programme for people with chronic pain. Journal of Clinical Nursing 21(23-24): 3372-3381

Johnston, O.; Startup, H.; Lavender, A.; Godfrey, E.; Schmidt, U. 2010: Therapeutic writing as an intervention for symptoms of bulimia nervosa: effects and mechanism of change. International Journal of Eating Disorders 43(5): 405-419

Patel, A.B.; Dibley, M.J.; Mamtani, M.; Badhoniya, N.; Kulkarni, H. 2013: Therapeutic zinc and copper supplementation in acute diarrhea does not influence short-term morbidity and growth: double-blind randomized controlled trial. Pediatric Infectious Disease Journal 32(1): 91-93

Anonymous 1954: Therapeutic, prophylactic, and diagnostic substances: Introduction. Bulletin of the World Health Organization 10(6): 867-873

Casey, M.Joseph.; Salzman, T.A. 2014: Therapeutic, prophylactic, untoward, and contraceptive effects of combined oral contraceptives: catholic teaching, natural law, and the principle of double effect when deciding to prescribe and use. American Journal of Bioethics: Ajob 14(7): 20-34

Nantha, Y.S. 2014: Therapeutic-diagnostic Evaluation of Chronic Cough Amongst Adults: Causes, Symptoms and Management at the Primary Care Level, Malaysia. Journal of Family Medicine and Primary Care 3(3): 207-212

Velazquez-Sanchez, C.; Ferragud, A.; Renau-Piqueras, J.; Canales, J.J. 2011: Therapeutic-like properties of a dopamine uptake inhibitor in animal models of amphetamine addiction. International Journal of Neuropsychopharmacology 14(5): 655-665

Lees, F.A. 1880: Therapeutical Experiences with the Digestive Ferments. British Medical Journal 1(1003): 438-439

Jones, C.H. 1862: St. Mary's Hospital. British Medical Journal 2(101): 577-580

May, G. 1868: On the Treatment of Injuries and of Certain Diseased States of the Abdomen. British Medical Journal 1(378): 298-299

Vovsi, M.S. 1945: Therapeutical aid in the Red Army. Voenno-Meditsinskii Zhurnal 1945: 3-7

Dumitrache-Rujinski, S.; Croitoru, A.; Bogdan, M.A. 2012: Therapeutical approach in severe exacerbation of COPD associating obstructive sleep apnoea and obesity. Pneumologia 61(2): 117-119

Babić, G.S.ć; Zlatanović, G.; Jocić, J.D.ć; Cekić, S.; Vujanović, M. 2010: Therapeutical approach to dry eye syndrome. Medicinski Pregled 63(11-12): 793-800

Ciaccio, M.; Bivona, G.; Bellia, C. 2008: Therapeutical approach to plasma homocysteine and cardiovascular risk reduction. Therapeutics and Clinical Risk Management 4(1): 219-224

Prignano, F.; Ortonne, J.-P.; Buggiani, G.; Lotti, T. 2007: Therapeutical approaches in melasma. Dermatologic Clinics 25(3): 337-342 Viii

Bahia, M.T.; Diniz, L.ív.d.F.; Mosqueira, V.C.F. 2014: Therapeutical approaches under investigation for treatment of Chagas disease. Expert Opinion on Investigational Drugs 23(9): 1225-1237

De Blic, J. 2007: Therapeutical compliance in asthmatic children. Recommendations for clinical practice. Revue des Maladies Respiratoires 24(4 Part 1): 419-425

Witzigmann, H.; Wiedmann, M.; Wittekind, C.; Mössner, J.; Hauss, J. 2008: Therapeutical concepts and results for Klatskin tumors. Deutsches Arzteblatt International 105(9): 156-161

Mitu, O.; Mitu, F.; Constantin, S.; Cojocaru, E.; Leon, M.-M. 2014: Therapeutical considerations in associated atrial fibrillation and heart failure. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 118(3): 624-630

Xu, X.; Stockhammer, F.; Schmitt, A.; Casalegno-Garduno, R.; Enders, A.; Mani, J.; Classen, C.F.; Linnebacher, M.; Freund, M.; Schmitt, M. 2012: Therapeutical doses of temozolomide do not impair the function of dendritic cells and CD8+ T cells. International Journal of Oncology 40(3): 764-772

Hong, L.; Juanjuan, Z.; Xiaoxiang, Z.; Wei, W. 2014: Therapeutical effect of Radix Aconiti and Astragalus extracts on models of experimental bradycardia animal. Pakistan Journal of Pharmaceutical Sciences 27(3): 439-444

Chen, W.; Zhang, H-Bin.; Fu, Y.; Sima, H.; Yang, N.; Yang, G-Shun. 2010: Therapeutical effect of combined hepatic resection and fenestration on patients with severe adult polycystic liver disease. Zhonghua Gan Zang Bing Za Zhi 18(1): 41-44

Fonseca Junior, N.Lopes.da.; Cha, S.Bok.; Cartum, J.; Rehder, Jé.Ricardo.Carvalho.Lima. 2008: Therapeutical effectiveness of interferon alpha in a child with craniofacial giant hemangioma: case report. Arquivos Brasileiros de Oftalmologia 71(3): 423-426

Guo, H.; Jiang, C.; Sun, X. 2014: Therapeutical effects and mechanism of salubrinal combined with ulinastatin on treating paraquat poisoning. Cell Biochemistry and Biophysics 70(3): 1559-1563

Chen, J.; Yang, X.-l.; Zhou, Z.-l.; Li, J.-m.; Tan, H.-b. 2007: Therapeutical efficacy of routine intra-aortic balloon pump support in patients with high-risk acute myocardial infarction undergoing percutaneous coronary intervention. Nan Fang Yi Ke da Xue Xue Bao 27(12): 1927-1928

Putkonen, T. 1948: Therapeutical experiments with penicillin in lymphogranulomatosis benigna Schaumann. Acta Dermato-Venereologica 28(2): 171-173

Feitosa-Filho, G.Soares.; Sena, J.Pinheiro.; Guimarães, Hélio.Penna.; Lopes, R.Delascio. 2009: Therapeutical hypothermia after cardiopulmonary resuscitation: evidences and practical issues. Revista Brasileira de Terapia Intensiva 21(1): 65-71

de Araújo Elias, A.Catarina.; Giglio, J.Sales.; de Mattos Pimenta, C.Andrucioli.; El-Dash, L.Gentry. 2006: Therapeutical intervention, relaxation, mental images, and spirituality (RIME) for spiritual pain in terminal patients. A training program. TheScientificWorldJournal 6: 2158-2169

Lukanova, M.; Miteva, I.; Gorgioski, S.; Popov, I. 2008: Therapeutical management of the most frequent gynaecological diseases and chronic pelvic pain in the Gynaecological Clinic, UMPHAT "Dr. G. Stransky"-Pleven in the period 2004-2007. Akusherstvo i ginekologiia 47(4): 28-34

Andreev, K.; Graser, A.; Maier, A.; Mousset, S.; Finotto, S. 2012: Therapeutical measures to control airway tolerance in asthma and lung cancer. Frontiers in Immunology 3: 216

Randerath, W.J. 2009: Therapeutical options for the treatment of Cheyne-Stokes respiration. Swiss Medical Weekly 139(9-10): 135-139

Klimek, L.; Pfaar, O.; Grevers, G. 2009: Therapeutical options in allergic rhinitis. MMW Fortschritte der Medizin 151(9): 31-34

Stanisz, H.; Tilgen, W.; Rass, K. 2009: Therapeutical options in malignant skin tumours. MMW Fortschritte der Medizin 151(39): 34-38

Pătraşcu, T.; Doran, H.; Catrina, E.; Mihalache, O. 2012: Therapeutical options in sigmoid diverticulitis. when should we operate?. Chirurgia 107(6): 715-721

Ginghină, C.; Crăciunescu, I.; Iorga, V. 2006: Therapeutical perspectives for apoptosis modulation in cardiovascular disease. Romanian Journal of Internal Medicine 44(3): 213-222

Leleu-Chavain, N.; Desreumaux, P.; Chavatte, P.; Millet, R.ég. 2013: Therapeutical potential of CB₂ receptors in immune-related diseases. Current Molecular Pharmacology 6(3): 183-203

Madonna, S.; Scarponi, C.; Doti, N.; Carbone, T.; Cavani, A.; Scognamiglio, P.L.; Marasco, D.; Albanesi, C. 2013: Therapeutical potential of a peptide mimicking the SOCS1 kinase inhibitory region in skin immune responses. European Journal of Immunology 43(7): 1883-1895

Husmann, M.; Barton, M. 2007: Therapeutical potential of direct thrombin inhibitors for atherosclerotic vascular disease. Expert Opinion on Investigational Drugs 16(5): 563-567

Landi, L.; Regoli, G.; Roversi, A.; Mitello, L. 2008: Therapeutical rehabilitation project and burnout: a experience of quali-quantitative research in a psychiatric department. Professioni Infermieristiche 61(2): 112-119

Galie, N.; Grigorie, V. 2009: Therapeutical solutions for non-malignant eso-bronchial fistulas. Journal of Medicine and Life 2(1): 104-109

Gironell, A. 2007: Therapeutical strategies for essential tremor. Medicina Clinica 129(16): 632-637

Charlier, R. 1947: Therapeutical studies in bronchial asthma with the aerosols of aleudrin. Medical Times 75(10): 277-286

Franklin, B.S.; Ishizaka, S.T.; Lamphier, M.; Gusovsky, F.; Hansen, H.; Rose, J.; Zheng, W.; Ataíde, M.Antônio.; de Oliveira, R.B.; Golenbock, D.T.; Gazzinelli, R.T. 2011: Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria. Proceedings of the National Academy of Sciences of the United States of America 108(9): 3689-3694

García B, L.; Gálvez G, J.; Armendáriz B, J. 2007: Therapeutical targets for revert liver fibrosis. Revista Medica de Chile 135(6): 783-791

Iannitti, T.; Palmieri, B. 2010: Therapeutical use of probiotic formulations in clinical practice. Clinical Nutrition 29(6): 701-725

Crippa, J.é A.S.; Zuardi, A.W.; Hallak, J.E.C. 2010: Therapeutical use of the cannabinoids in psychiatry. Revista Brasileira de Psiquiatria 32(Suppl 1): S56-S66

Mora Ripoll, R.; García Rodera, M.C. 2008: Therapeutical value of laughter in medicine. Medicina Clinica 131(18): 694-698

Pielesz, A.; Paluch, J. 2012: Therapeutically active dressings--biomaterials in a study of collagen glycation. Polimery W Medycynie 42(2): 115-120

Latif, N. 1947: Therapeutically active stilbenes. Journal of the Egyptian Medical Association 30(5): 247-255

Jandrić, S.D. 2007: Therapeutically effect of the physical procedures on the elbow contractures in children with supracondylar humerus fractures. Acta Chirurgica Iugoslavica 54(2): 39-43

Reid, D.W.; Dalton, E.J.; Laderoute, K.; Doell, F.K.; Nguyen, T. 2006: Therapeutically induced changes in couple identity: the role of we-ness and interpersonal processing in relationship satisfaction. Genetic Social and General Psychology Monographs 132(3): 241-284

Levin, P.; Wei, W.; Miao, R.; Ye, F.; Xie, L.; Baser, O.; Gill, J. 2015: Therapeutically interchangeable? a study of real-world outcomes associated with switching basal insulin analogues among US patients with type 2 diabetes mellitus using electronic medical records data. Diabetes Obesity and Metabolism 17(3): 245-253

Hewitt, S.K. 2008: Therapeutically managing reunification after abuse allegations. Journal of Child Sexual Abuse 17(1): 17-19

Pollak, P.T. 2010: Therapeutically relevant blood pressure differences with two nifedipine (60 mg) osmotic delivery systems of differing design: three case reports. International Journal of Clinical Pharmacology and Therapeutics 48(6): 400-404

Chan, Y.Chi.; Leung, F.Ping.; Wong, W.Tak.; Tian, X.Yu.; Yung, L.Ming.; Lau, C.Wai.; Tsang, S.Ying.; Yao, X.; Chen, Z.Yu.; Huang, Y. 2010: Therapeutically relevant concentrations of raloxifene dilate pressurized rat resistance arteries via calcium-dependent endothelial nitric oxide synthase activation. Arteriosclerosis Thrombosis and Vascular Biology 30(5): 992-999

Sotlar, K. 2007: Therapeutically relevant mutations in the receptor tyrosine kinase KIT in mastocytosis. Verhandlungen der Deutschen Gesellschaft für Pathologie 91: 169-176

Morè, L.; Gravius, A.; Nagel, J.; Valastro, B.; Greco, S.; Danysz, W. 2008: Therapeutically relevant plasma concentrations of memantine produce significant L-N-methyl-D-aspartate receptor occupation and do not impair learning in rats. Behavioural Pharmacology 19(7): 724-734

Schoeberl, B.; Pace, E.A.; Fitzgerald, J.B.; Harms, B.D.; Xu, L.; Nie, L.; Linggi, B.; Kalra, A.; Paragas, V.; Bukhalid, R.; Grantcharova, V.; Kohli, N.; West, K.A.; Leszczyniecka, M.; Feldhaus, M.J.; Kudla, A.J.; Nielsen, U.B. 2009: Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis. Science Signaling 2(77): Ra31

Graci, J.D.; Cameron, C.E. 2008: Therapeutically targeting RNA viruses via lethal mutagenesis. Future Virology 3(6): 553-566

Falnikar, A.; Li, K.; Lepore, A.C. 2015: Therapeutically targeting astrocytes with stem and progenitor cell transplantation following traumatic spinal cord injury. Brain Research 1619: 91-103

Smith, M.E.; Cimica, V.; Chinni, S.; Jana, S.; Koba, W.; Yang, Z.; Fine, E.; Zagzag, D.; Montagna, C.; Kalpana, G.V. 2011: Therapeutically targeting cyclin D1 in primary tumors arising from loss of Ini1. Proceedings of the National Academy of Sciences of the United States of America 108(1): 319-324

Feng, M.; Gao, W.; Wang, R.; Chen, W.; Man, Y.-G.; Figg, W.D.; Wang, X.W.; Dimitrov, D.S.; Ho, M. 2013: Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma. Proceedings of the National Academy of Sciences of the United States of America 110(12): E1083-E1091

Lee, Y.; Lee, S.-R.; Choi, S.S.; Yeo, H.-G.; Chang, K.-T.; Lee, H.J. 2014: Therapeutically targeting neuroinflammation and microglia after acute ischemic stroke. Biomed Research International 2014: 297241

Rek, A.; Krenn, E.; Kungl, A.J. 2009: Therapeutically targeting protein-glycan interactions. British Journal of Pharmacology 157(5): 686-694

Driscoll, J.J.; Dechowdhury, R. 2010: Therapeutically targeting the SUMOylation, Ubiquitination and Proteasome pathways as a novel anticancer strategy. Targeted Oncology 5(4): 281-289

Valeri, C.Robert.; Ragno, G. 2010: Therapeuticefficacy of platelet transfusion in patients with acute leukemia. Transfusion 50(11): 2504; Author Reply 2505-6

Anonymous 1921: Therapeutics of Radium. British medical journal 1(3147): 609-611

Govorkova, E.A.; McCullers, J.A. 2013: Therapeutics against influenza. Current Topics in Microbiology and Immunology 370: 273-300

Magee, L.A.; Lowe, S.; Douglas, M.J.; Kathirgamanathan, A. 2011: Therapeutics and anaesthesia. Best Practice and Research. Clinical Obstetrics and Gynaecology 25(4): 477-490

Stanulović, M. 1995: Therapeutics and clinical pharmacology of pediatric age. Srpski Arhiv Za Celokupno Lekarstvo 123(Suppl 1): 1-4

Gordon, K.B.; Satoskar, R. 2008: Therapeutics and immune-mediated skin disease. Current Directions in Autoimmunity 10: 359-372

Young, E.R. 1988: Therapeutics and sedation in dentistry. Canadian Family Physician Medecin de Famille Canadien 34: 1403-1407

Mattox, C. 1995: Therapeutics and techniques and glaucoma care updates: management of the leaking bleb. Journal of Glaucoma 4(5): 370-374

Fingeret, M. 2012: Therapeutics and the profession of optometry-a look back. Optometry and Vision Science: Official Publication of the American Academy of Optometry 89(4): 372

Wright, R.O.; Fields, N. 2008: Therapeutics and toxicology. Current Opinion in Pediatrics 20(2): 171

Keeling, K.M.; Xue, X.; Gunn, G.; Bedwell, D.M. 2014: Therapeutics based on stop codon readthrough. Annual Review of Genomics and Human Genetics 15: 371-394

Racanelli, A.C.; Rothbart, S.B.; Heyer, C.L.; Moran, R.G. 2009: Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition. Cancer Research 69(13): 5467-5474

Lertsapcharoen, P. 2014: Therapeutics catheterization in pediatric cardiology. Southeast Asian Journal of Tropical Medicine and Public Health 45(Suppl 1): 86-87

Francke, D.E. 1948: Therapeutics committee and the hospital formulary. Bulletin. American Society of Hospital Pharmacists 5(1): 6-13

Ashlock, M.A.; Olson, E.R. 2011: Therapeutics development for cystic fibrosis: a successful model for a multisystem genetic disease. Annual Review of Medicine 62: 107-125

Foff, E.P.; Mahadevan, M.S. 2011: Therapeutics development in myotonic dystrophy type 1. Muscle and Nerve 44(2): 160-169

Bush, A.I.; Tanzi, R.E. 2008: Therapeutics for Alzheimer's disease based on the metal hypothesis. Neurotherapeutics: the Journal of the American Society for Experimental Neurotherapeutics 5(3): 421-432

Dodson, E.R.; Zee, P.C. 2010: Therapeutics for Circadian Rhythm Sleep Disorders. Sleep Medicine Clinics 5(4): 701-715

Lawrence, A.J. 2007: Therapeutics for alcoholism: what's the future?. Drug and Alcohol Review 26(1): 3-8

Usami, M.; Kotani, J. 2007: Therapeutics for bacterial translocation. Nihon Geka Gakkai Zasshi 108(3): 143-146

Shineman, D.W.; Salthouse, T.A.; Launer, L.J.; Hof, P.R.; Bartzokis, G.; Kleiman, R.; Luine, V.; Buccafusco, J.J.; Small, G.W.; Aisen, P.S.; Lowe, D.A.; Fillit, H.M. 2010: Therapeutics for cognitive aging. Annals of the new York Academy of Sciences 1191(Suppl 1): E1-15

Simmons, C.P.; Wolbers, M.; Nguyen, M.N.; Whitehorn, J.; Shi, P.Y.; Young, P.; Petric, R.; Nguyen, V.V.C.; Farrar, J.; Wills, B. 2012: Therapeutics for dengue: recommendations for design and conduct of early-phase clinical trials. Plos Neglected Tropical Diseases 6(9): E1752

Shurtleff, A.C.; Nguyen, T.L.; Kingery, D.A.; Bavari, S. 2012: Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design. Expert Opinion on Drug Discovery 7(10): 935-954

Ben-Zacharia, A.B. 2011: Therapeutics for multiple sclerosis symptoms. Mount Sinai Journal of Medicine new York 78(2): 176-191

Gonzalez, F.F.; Ferriero, D.M. 2008: Therapeutics for neonatal brain injury. Pharmacology and Therapeutics 120(1): 43-53

Roper-Hall, H.T. 1948: Therapeutics in dentistry. Dental Gazette 15(2): 76-80

Renson, C.E.; Stanway, A.T.; Renson, C.E.; Stanway, A.T. 2013: Therapeutics in dentistry. Antibiotics. 1973. Dental Update 40(4): 318

Kim, J.; Kim, S.Min.; Nguyen, H.Cam.Thuy.; Redondo, M.Jose. 2012: Therapeutics in pediatric diabetes: insulin and non-insulin approaches. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni. Pharmacological research 65(1): 1-4

Díez Pérez, A. 2007: Therapeutics issues in osteoporosis. Medicina Clinica 129(20): 773-774

Machu, T.K. 2011: Therapeutics of 5-HT3 receptor antagonists: current uses and future directions. Pharmacology and Therapeutics 130(3): 338-347

Anand, R.; Gill, K.D.; Mahdi, A.A. 2014: Therapeutics of Alzheimer's disease: Past, present and future. Neuropharmacology 76 Pt A: 27-50

Li, L.; Chen, B.-A. 2012: Therapeutics of Burkitt lymphoma in adults - review. Zhongguo Shi Yan Xue Ye Xue Za Zhi 20(5): 1289-1292

Gardiner, C.F. 1910: Therapeutics of Cold in Colorado. Transactions of the American Climatological Association for the year . American Climatological Association 26: 62-71

Yen, J.Y.; Garamszegi, S.; Geisbert, J.B.; Rubins, K.H.; Geisbert, T.W.; Honko, A.; Xia, Y.; Connor, J.H.; Hensley, L.E. 2011: Therapeutics of Ebola hemorrhagic fever: whole-genome transcriptional analysis of successful disease mitigation. Journal of Infectious Diseases 204(Suppl 3): S1043-S1052

Genth, C. 1888: Therapeutics of Hay Fever. British Medical Journal 1(1433): 1268

Roman, C.V. 1912: Therapeutics of Pulmonary Tuberculosis. Journal of the National Medical Association 4(1): 1-7

Valla, V. 2010: Therapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps. Experimental Diabetes Research 2010: 178372

Corti, R.; Doweck, J.; Schenone, L.; Améndola, R.; Giordano Romano, A. 2008: Therapeutics of infection by Helicobacter pylori in 2008. Revista de Gastroenterologia de Mexico 73(2): 93-105

Wong, V.W.-s.; Fan, J.-g.; Chan, H.L.-y. 2007: Therapeutics of non-alcoholic fatty liver disease. Zhonghua Gan Zang Bing Za Zhi 15(9): 687-688

Sounouvou, I.; Tchabi, S.; Monteiro, S.; Yehouessi, L.; Doutetien, C.; Bassabi, S.K. 2012: Therapeutics of primary open-angle glaucoma in Cotonou: a series of 224 cases. Journal Francais d'Ophtalmologie 35(2): 100-105

Saini, R.; Saini, S.; Sharma, S. 2011: Therapeutics of stem cells in periodontal regeneration. Journal of Natural Science Biology and Medicine 2(1): 38-42

Long, W.D. 1947: Therapeutics of the nephritides. Journal of the American Osteopathic Association 46(6): 358-360

Cook, A.B. 1946: Therapeutics of the vitamin B complex. Journal of the Christian Medical Association of India 21: 60-68

Eley, R.C.; Berenberg, W. 1949: Therapeutics of tuberculosis in infancy and childhood with special reference to chemotherapy. Pediatrics 3(4): 549-554

Wallitt, E.J.W.; Jevon, M.; Hornick, P.I. 2007: Therapeutics of vein graft intimal hyperplasia: 100 years on. Annals of Thoracic Surgery 84(1): 317-323

Rahmani, A.H.; Albutti, A.S.; Aly, S.M. 2014: Therapeutics role of olive fruits/oil in the prevention of diseases via modulation of anti-oxidant, anti-tumour and genetic activity. International Journal of Clinical and Experimental Medicine 7(4): 799-808

Launay, E.; Bingen, E.; Cohen, R. 2012: Therapeutics strategies for the management of urinary tract infection in children. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 19(Suppl 3): S109-S116

Koizumi, K.; Kato, S.; Sakurai, H.; Hashimoto, I.; Yasumoto, K.; Saiki, I. 2012: Therapeutics target of CXCR4 and its downstream in peritoneal carcinomatosis of gastric cancer. Frontiers in Bioscience 4(1): 269-276

Blease, K. 2008: Therapeutics targeting IL-13 for the treatment of pulmonary inflammation and airway remodeling. Current Opinion in Investigational Drugs 9(11): 1180-1184

Katoh, M. 2013: Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular mi RNAs and signaling networks (Review). International Journal of Molecular Medicine 32(4): 763-767

Risbano, M.G.; Gladwin, M.T. 2013: Therapeutics targeting of dysregulated redox equilibrium and endothelial dysfunction. Handbook of Experimental Pharmacology 218: 315-349

Mocellin, S.; Nitti, D. 2008: Therapeutics targeting tumor immune escape: towards the development of new generation anticancer vaccines. Medicinal Research Reviews 28(3): 413-444

Shababi, M.; Mattis, V.B.; Lorson, C.L. 2010: Therapeutics that directly increase SMN expression to treat spinal muscular atrophy. Drug News and Perspectives 23(8): 475-482

Morris, N. 1946: Therapeutics throughout the ages. Australian Hospital 13(5): 7; 16

Kaufmann, C. 1934: Therapeutics with Hormones of the Ovary : (Section of Therapeutics and Pharmacology). Proceedings of the Royal Society of Medicine 27(7): 849-863

Alvarim, L.T.; Nucci, L.P.; Mamani, J.B.; Marti, L.C.; Aguiar, M.F.; Silva, H.R.; Silva, G.S.; Nucci-da-Silva, M.P.; DelBel, E.A.; Gamarra, L.F. 2014: Therapeutics with SPION-labeled stem cells for the main diseases related to brain aging: a systematic review. International Journal of Nanomedicine 9: 3749-3770

Nunes, A.; Al-Jamal, K.T.; Kostarelos, K. 2012: Therapeutics, imaging and toxicity of nanomaterials in the central nervous system. Journal of Controlled Release: Official Journal of the Controlled Release Society 161(2): 290-306

Pitt, B. 2010: Therapeutics. Adding NT-proBNP-guided management to multidisciplinary care reduced heart failure rehospitalization days. Annals of Internal Medicine 153(2): Jc1-Jc8

Sultan, S.; Forsmark, C.E. 2010: Therapeutics. Review: enteral nutrition reduces mortality, multiple organ failure, and systemic infection more than TPN in acute pancreatitis. Annals of Internal Medicine 153(2): Jc1-Jc6

Schectman, J. 2010: Therapeutics. Influenza vaccination of children and adolescents decreased influenza infection in nonvaccinated community members. Annals of Internal Medicine 153(2): Jc1

Elley, C..Raina.; Selak, V. 2010: Therapeutics. Intensive blood pressure control did not prevent major CV events more than standard control in type 2 diabetes. Annals of Internal Medicine 153(2): Jc1

Crandall, C.J. 2010: Therapeutics. Lasofoxifene reduced vertebral fractures in postmenopausal women with osteoporosis. Annals of Internal Medicine 153(2): Jc1

Smadja, D.M. 2013: Therapeutics. new anticoagulants: stop the controversy!. La Revue du Praticien 63(8): 1044-1047

Sultan, S.; Forsmark, C.E. 2010: Therapeutics. Review: enteral nutrition reduces mortality, multiple organ failure, and systemic infection more than TPN in acute pancreatitis. Annals of Internal Medicine 153(2): Jc1-Jc6

White, R.H. 2010: Therapeutics. Review: heparin and mechanical compression are similar in reducing postsurgical VTE risk, but heparin increases bleeding. Annals of Internal Medicine 153(2): Jc1-Jc7

Tsapas, A. 2010: Therapeutics. Review: metformin does not increase risk for lactic acidosis in type 2 diabetes. Annals of Internal Medicine 153(2): Jc1-Jc9

Stanbrook, M.B. 2010: Therapeutics. Review: tiotropium does not increase risk for cardiovascular events in chronic obstructive pulmonary disease. Annals of Internal Medicine 153(2): Jc1

Casci, T. 2011: Therapeutics: RNA device rewires cellular networks. Nature reviews. Cancer 11(1): 8

Seton-Rogers, S. 2014: Therapeutics: delving deeper into resistance. Nature reviews. Cancer 14(1): 7

Lafortune, J.G. 1956: Therapeutique Nouvelle en Neuro-Pathologie. Canadian Journal of Comparative Medicine and Veterinary Science 20(4): 116-129

Prior, D.J. 1991: Control of Central and Peripheral Targets by a Multifunctional Peptidergic Interneuron. Biological Bulletin 180(2): 295-300

Sabuncuoglu, O. 2014: Therapia, Istanbul. American Journal of Psychiatry 171(7): 732

Kang, W.-J.; Xia, C.-B.; Deng, Y.-J.; Zhang, J.-S. 2012: Therapic choice of intertrochanteric fracture of femur in aged patient. Zhongguo Gu Shang 25(1): 35-38

Paredes, K.; Pastor, F.J.; Capilla, J.; Sutton, D.A.; Mayayo, E.; Fothergill, A.W.; Guarro, J. 2015: Therapies against murine Candida guilliermondii infection, relationship between in vitro antifungal pharmacodynamics and outcome. Revista Iberoamericana de Micologia 32(1): 34-39

Mitka, M. 2008: Therapies aim to boost "good" cholesterol. JAMA 299(5): 509-510

Keymeulen, B. 2008: Therapies aimed at preservation or restoration of beta cell function in type 1 diabetes. Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 70(2): 85-103

Quigley, E.M.M. 2011: Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies. Gastroenterology Clinics of North America 40(1): 207-222

Lipkin, D.; Kwon, Y. 2014: Therapies and nursing care of women with vulvar dermatologic disorders. Journal of Obstetric Gynecologic and Neonatal Nursing: Jognn 43(2): 246-252

Grenier, N.; Trillaud, H.; Palussière, J.; Mougenot, C.; Quesson, B.; Denis De Senneville, B.; Moonen, C. 2007: Therapies by focused ultrasound. Journal de Radiologie 88(11 Part 2): 1787-1800

Pinton, G.; Manente, A.G.; Tavian, D.; Moro, L.; Mutti, L. 2013: Therapies currently in Phase Ii trials for malignant pleural mesothelioma. Expert Opinion on Investigational Drugs 22(10): 1255-1263

O'Dell, J.R.; Mikuls, T.R.; Taylor, T.H.; Ahluwalia, V.; Brophy, M.; Warren, S.R.; Lew, R.A.; Cannella, A.C.; Kunkel, G.; Phibbs, C.S.; Anis, A.H.; Leatherman, S.; Keystone, E.; Abrams, P.; Adamski, L.; Ageton, C.; Allen, J.; Allred, D.; Ardizzi, R.; Badua, E.; Bond, C.; Boulet, C.; Brady, L.; Clairmont, J.; Clark, E.; Cxypoliski, R.; Dailey, A.; De Guzman, E.; Detwiler, J.; Ding, G.; Dinnella, J.; Duarte, B.; Farquharson, J.; Godina, J.; Goodfellow, E.; Guillet, C.; Hanf, H.; Huggard, A.; Jamgotchian, N.; Khalaghizadeh, S.; Kittelsrud, J.; Lea, D.; Lutz, A.; Majeski, P.; Marr, C.; Martin, E.; Milton, M.G.; Milton, R.; Mitchell, S.; Morean-Wright, C.; Nelson, C.; Nelson, J.; Pattison-Chri 2013: Therapies for active rheumatoid arthritis after methotrexate failure. New England Journal of Medicine 369(4): 307-318

Hofmann, L.V. 2009: Therapies for acute and chronic deep venous thrombosis. Clinical Advances in Hematology and Oncology: H&o 7(5): 301-303

Goldberg, R.J.; Ismailov, R.M.; Patlolla, V.; Lessard, D.; Spencer, F.A. 2008: Therapies for acute heart failure in patients with reduced kidney function: a community-based perspective. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 51(4): 594-602

Oki, K.; Yamane, K. 2007: Therapies for adrenal insufficiency. Expert Opinion on PharmacoTherapy 8(9): 1283-1291

Neumann, P.J.; Bliss, S.K.; Chambers, J.D. 2012: Therapies for advanced cancers pose a special challenge for health technology assessment organizations in many countries. Health Affairs 31(4): 700-708

Martineau, L.; Noreau, A.; Dupré, N. 2014: Therapies for ataxias. Current Treatment Options in Neurology 16(7): 300

Tripathi, D. 2009: Therapies for bleeding gastric varices: is the fog starting to clear?. Gastrointestinal Endoscopy 70(5): 888-891

Cutroneo, K.R.; White, S.L.; Phan, S.H.; Ehrlich, H.Paul. 2007: Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta1 induced collagen gene expression. Journal of Cellular Physiology 211(3): 585-589

Trüeb, R.M. 2009: Therapies for childhood psoriasis. Current Problems in Dermatology 38: 137-159

Fogleman, C.D. 2012: Therapies for children with autism spectrum disorders. American Family Physician 85(9): 878-880

Mu, Y.; Li, N.; Guan, L.; Wang, C.; Shang, S.; Wang, Y. 2012: Therapies for children with cerebral palsy: A Web of Science-based literature analysis. Neural Regeneration Research 7(33): 2632-2639

Tong, T.R. 2009: Therapies for coronaviruses. Part 2: Inhibitors of intracellular life cycle. Expert Opinion on Therapeutic Patents 19(4): 415-431

Tong, T.R. 2009: Therapies for coronaviruses. Part i of Ii -- viral entry inhibitors. Expert Opinion on Therapeutic Patents 19(3): 357-367

Auzou, P. 2009: Therapies for deglutition disorders in nervous system disease pathologies. Revue Neurologique (Paris) 165(Special Issue 4): F245-F255

Jones, M.C. 2007: Therapies for diabetes: pramlintide and exenatide. American Family Physician 75(12): 1831-1835

Bell, D.S.H.; Al Badarin, F.; O'Keefe, J.H. 2011: Therapies for diabetic dyslipidaemia. Diabetes Obesity and Metabolism 13(4): 313-325

Ponsford, J.R. 2011: Therapies for dopaminergic-induced dyskinesias in Parkinson disease. Annals of Neurology 70(4): 667; Author Reply 667-8

Roudebush, P.; Polzin, D.J.; Ross, S.J.; Towell, T.L.; Adams, L.G.; Dru Forrester, S. 2009: Therapies for feline chronic kidney disease. what is the evidence?. Journal of Feline Medicine and Surgery 11(3): 195-210

Panegyres, P.K.; Armari, E. 2013: Therapies for human prion diseases. American Journal of Neurodegenerative Disease 2(3): 176-186

Talele, S.S.; Xu, K.; Pariser, A.R.; Braun, M.M.; Farag-El-Massah, S.; Phillips, M.I.; Thompson, B.H.; Coté, T.R. 2010: Therapies for inborn errors of metabolism: what has the orphan drug act delivered?. Pediatrics 126(1): 101-106

Greenberg, J.; Goss, J.B. 2009: Therapies for insomnia and comorbid chronic obstructive pulmonary disease with a focus on ramelteon (rozerem). P and T: a Peer-Reviewed Journal for Formulary Management 34(9): 502-508

Iepsen, E.W.; Torekov, S.S.; Holst, J.J. 2014: Therapies for inter-relating diabetes and obesity - GLP-1 and obesity. Expert Opinion on PharmacoTherapy 15(17): 2487-2500

Kim, R.; Meyer, K.C. 2008: Therapies for interstitial lung disease: past, present and future. Therapeutic Advances in Respiratory Disease 2(5): 319-338

Skarbnik, A.P.; Smith, M.R. 2013: Therapies for mantle cell lymphoma: current challenges and a brighter future. Discovery Medicine 15(82): 177-187

Girgis, C.M.; Mokbel, N.; Digirolamo, D.J. 2014: Therapies for musculoskeletal disease: can we treat two birds with one stone?. Current Osteoporosis Reports 12(2): 142-153

Hanout, M.; Ferraz, D.; Ansari, M.; Maqsood, N.; Kherani, S.; Sepah, Y.J.; Rajagopalan, N.; Ibrahim, M.; Do, D.V.; Nguyen, Q.D. 2013: Therapies for neovascular age-related macular degeneration: current approaches and pharmacologic agents in development. Biomed Research International 2013: 830837

Lischer, G.H.; Nehra, A. 2003: Therapies for neurologic erectile dysfunction. Expert Review of Neurotherapeutics 3(5): 641-648

Anson, D.S.; McIntyre, C.; Byers, S. 2011: Therapies for neurological disease in the mucopolysaccharidoses. Current Gene Therapy 11(2): 132-143

Mahady, S. 2013: Therapies for nonalcoholic steatohepatitis. Gastroenterology and Hepatology 9(1): 40-42

Howland, R.H. 2013: Therapies for obesity and medication-associated weight gain. Journal of Psychosocial Nursing and Mental Health Services 51(5): 13-16

Gupta, A.K.; Daigle, D.; Paquet, M. 2015: Therapies for onychomycosis a systematic review and network meta-analysis of mycological cure. Journal of the American Podiatric Medical Association 105(4): 357-366

Poindexter, G.B.; Burkhart, C.N.; Morrell, D.S. 2009: Therapies for pediatric seborrheic dermatitis. Pediatric Annals 38(6): 333-338

Savage, K.J. 2011: Therapies for peripheral T-cell lymphomas. HEMATOLOGY. American Society of Hematology. Education Program 2011: 515-524

Zhang, F.-w.; Liao, Y.; Li, X.-y.; Chen, L.; Jin, H.-f.; Du, J.-b. 2011: Therapies for postural tachycardia syndrome in children. Zhonghua Er Ke Za Zhi 49(6): 428-432

Seferian, A.; Simonneau, G.ér. 2013: Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow?. European Respiratory Review: An Official Journal of the European Respiratory Society 22(129): 217-226

Miura, S.-i.; Saku, K. 2007: Therapies for raising high-density lipoprotein cholesterol. Internal Medicine 46(7): 339-340

Pipeling, M.R.; Fan, E. 2010: Therapies for refractory hypoxemia in acute respiratory distress syndrome. JAMA 304(22): 2521-2527

Grounds, M.D. 2014: Therapies for sarcopenia and regeneration of old skeletal muscles: more a case of old tissue architecture than old stem cells. Bioarchitecture 4(3): 81-87

Hassoun, P.M. 2009: Therapies for scleroderma-related pulmonary arterial hypertension. Expert Review of Respiratory Medicine 3(2): 187-196

Ong, G.S.Y.; Henley, D.E.; Hurley, D.; Turner, J.H.; Claringbold, P.G.; Fegan, P.G. 2010: Therapies for the medical management of persistent hypoglycaemia in two cases of inoperable malignant insulinoma. European Journal of Endocrinology 162(5): 1001-1008

Gupta, A.K.; Paquet, M.; Simpson, F.C. 2013: Therapies for the treatment of onychomycosis. Clinics in Dermatology 31(5): 544-554

Tosteson, A.N.A.; Burge, R.T.; Marshall, D.A.; Lindsay, R. 2008: Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations. American Journal of Managed Care 14(9): 605-615

Garratt, K.N.; Bailey, S.R. 2009: Therapies for type 2 diabetes and coronary artery disease. New England Journal of Medicine 361(14): 1407-1408; Author Reply 1409-1410

Kurukulasuriya, L.R.; Sowers, J.R. 2010: Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors. Cardiovascular Diabetology 9: 45

Bikdeli, B. 2014: Therapies for venous thromboembolism. JAMA 311(24): 2543

Fitton, J.H. 2011: Therapies from fucoidan; multifunctional marine polymers. Marine Drugs 9(10): 1731-1760

Crow, Y.J.; Vanderver, A.; Orcesi, S.; Kuijpers, T.W.; Rice, G.I. 2014: Therapies in Aicardi-Goutières syndrome. Clinical and Experimental Immunology 175(1): 1-8

Jankovic, J.; Poewe, W. 2012: Therapies in Parkinson's disease. Current Opinion in Neurology 25(4): 433-447

Gottlieb, R.M. 2008: Therapies in collision: introduction to Purcell. Journal of the American Psychoanalytic Association 56(3): 909-911

Harzstark, A.L.; Ryan, C.J. 2008: Therapies in development for castrate-resistant prostate cancer. Expert Review of Anticancer Therapy 8(2): 259-268

Kesselring, J.ür. 2013: Therapies in multiple sclerosis. Praxis 102(17): 1061-1067

Tsuboi, N.; Kawamura, T. 2014: Therapies in patients with IgA nephropathy. Internal Medicine 53(7): 649-650

Chabrol, B. 2010: Therapies in the Niemann-Pick type C disease. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 17(Suppl 2): S54-S57

Ommerborn, M.A.; Taghavi, J.; Singh, P.; Handschel, J.; Depprich, R.A.; Raab, W.H.M. 2011: Therapies most frequently used for the management of bruxism by a sample of German dentists. Journal of Prosthetic Dentistry 105(3): 194-202

Tomatsu, S.; Alméciga-Díaz, C.J.; Barbosa, H.; Montaño, A.M.; Barrera, L.A.; Shimada, T.; Yasuda, E.; Mackenzie, W.G.; Mason, R.W.; Suzuki, Y.; Orii, K.E.; Orii, T. 2013: Therapies of mucopolysaccharidosis IVA (Morquio a syndrome). Expert Opinion on Orphan Drugs 1(10): 805-818

Davidson, M.H. 2011: Therapies targeting exogenous cholesterol uptake: new insights and controversies. Current Atherosclerosis Reports 13(1): 95-100

Okura, H.; Takagi, T.; Yoshida, K. 2013: Therapies targeting inflammation after stent implantation. Current Vascular Pharmacology 11(4): 399-406

Jahnke, U.; McGee, V. 2008: Therapies targeting pain. Idrugs: the Investigational Drugs Journal 11(1): 13-15

Breitenbürger, W. 2010: Therapies that promote emancipation. Deutsches Arzteblatt International 107(33): 569; Author Reply 571-2

Borenstein, M.Süsskind.; Padilha, M.Itayra.Coelho.de.Souza.; Ribeiro, A.Alves.de.Almeida.; Pereira, V.Preve.; Ribas, Déa.Loes.; Costa, E. 2007: Therapies used in Hospital Colônia Sant'Ana: the cradle of psychiatry in Santa Catarina State, Brazil (1941-1960). Revista brasileira de enfermagem 60(6): 665-669

Heidenreich, A.; Witjes, W.P.J.; Bjerklund-Johansen, T.E.; Patel, A. 2012: Therapies used in prostate cancer patients by European urologists: data on indication with a focus on expectations, perceived barriers and guideline compliance related to the use of bisphosphonates. Urologia Internationalis 89(1): 30-38

Henkin, J.; Volpert, O.V. 2011: Therapies using anti-angiogenic peptide mimetics of thrombospondin-1. Expert Opinion on Therapeutic Targets 15(12): 1369-1386

Blagoev, K.B.; Wilkerson, J.; Stein, W.D.; Yang, J.; Bates, S.E.; Fojo, T. 2014: Therapies with diverse mechanisms of action kill cells by a similar exponential process in advanced cancers. Cancer Research 74(17): 4653-4662

Bush, J.; So, K.; Mason, T.; Occleston, N.L.; O'Kane, S.; Ferguson, M.W.J. 2010: Therapies with emerging evidence of efficacy: avotermin for the improvement of scarring. Dermatology Research and Practice 2010

Larrison, C.R.; Schoppelrey, S.L. 2011: Therapist Effects on Disparities Experienced by Minorities Receiving Services for Mental Illness. Research on Social Work Practice 21(6): 727-736

Podell, J.L.; Kendall, P.C.; Gosch, E.A.; Compton, S.N.; March, J.S.; Albano, A.-M.; Rynn, M.A.; Walkup, J.T.; Sherrill, J.T.; Ginsburg, G.S.; Keeton, C.P.; Birmaher, B.; Piacentini, J.C. 2013: Therapist Factors and Outcomes in CBT for Anxiety in Youth. Professional Psychology Research and Practice 44(2): 89-98

Haine-Schlagel, R.; Brookman-Frazee, L.; Fettes, D.L.; Baker-Ericzén, M.; Garland, A.F. 2012: Therapist Focus on Parent Involvement in Community-Based Youth Psychotherapy. Journal of Child and Family Studies 21(4): 646-656

Wang, S.; Kim, B.S.K. 2010: Therapist Multicultural Competence, Asian American Participants' Cultural Values, and Counseling Process. Journal of counseling psychology 57(4): 394-401

Dudley, D.Raphael.; McCloskey, K.; Kustron, D.A. 2008: Therapist Perceptions of Intimate Partner Violence: a Replication of Harway and Hansen2019;s Study After more than a Decade. Journal of Aggression Maltreatment and Trauma 17(1): 80-102

Mutchler, M.; Anderson, S. 2010: Therapist Personal Agency: a model for examining the training context. Journal of Marital and Family Therapy 36(4): 511-525

Frueh, B.C.; Monnier, J.; Grubaugh, A.L.; Elhai, J.D.; Yim, E.; Knapp, R. 2007: Therapist adherence and competence with manualized cognitive-behavioral therapy for PTSD delivered via videoconferencing technology. Behavior Modification 31(6): 856-866

Schoenwald, S.K.; Carter, R.E.; Chapman, J.E.; Sheidow, A.J. 2008: Therapist adherence and organizational effects on change in youth behavior problems one year after multisystemic therapy. Administration and Policy in Mental Health 35(5): 379-394

Robbins, M.S.; Feaster, D.J.; Horigian, V.E.; Puccinelli, M.J.; Henderson, C.; Szapocznik, Jé. 2011: Therapist adherence in brief strategic family therapy for adolescent drug abusers. Journal of Consulting and Clinical Psychology 79(1): 43-53

Brauhardt, A.; de Zwaan, M.; Herpertz, S.; Zipfel, S.; Svaldi, J.; Friederich, H.-C.; Hilbert, A. 2014: Therapist adherence in individual cognitive-behavioral therapy for binge-eating disorder: assessment, course, and predictors. Behaviour Research and Therapy 61: 55-60

Smith, D.C.; Hall, J.A.; Jang, M.; Arndt, S. 2009: Therapist adherence to a motivational-interviewing intervention improves treatment entry for substance-misusing adolescents with low problem perception. Journal of Studies on Alcohol and Drugs 70(1): 101-105

Morland, L.A.; Greene, C.J.; Grubbs, K.; Kloezeman, K.; Mackintosh, M.-A.; Rosen, C.; Frueh, B.C. 2011: Therapist adherence to manualized cognitive-behavioral therapy for anger management delivered to veterans with PTSD via videoconferencing. Journal of Clinical Psychology 67(6): 629-638

Webb, C.A.; Derubeis, R.J.; Barber, J.P. 2010: Therapist adherence/competence and treatment outcome: a meta-analytic review. Journal of Consulting and Clinical Psychology 78(2): 200-211

Geller, S.Melissa.; Greenberg, L.S.; Watson, J.Cherry. 2010: Therapist and client perceptions of therapeutic presence: the development of a measure. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 20(5): 599-610

Marmarosh, C.; Whipple, R.; Schettler, M.; Pinhas, S.; Wolf, J.; Sayit, S. 2009: Therapist and patient mental representations: the early therapy relationship in long-term psychodynamic psychotherapy. Journal of the American Psychoanalytic Association 57(2): 432-438

Manne, S.L.; Kashy, D.A.; Rubin, S.; Hernandez, E.; Bergman, C. 2012: Therapist and patient perceptions of alliance and progress in psychological therapy for women diagnosed with gynecological cancers. Journal of Consulting and Clinical Psychology 80(5): 800-810

Prasko, J.; Vyskocilová, J.; Mozny, P.; Novotny, M.; Slepecky, M. 2011: Therapist and supervisor competencies in cognitive behavioural therapy. Neuro Endocrinology Letters 32(6): 781-789

Jacobs, D.F.; Silvernail, J.L. 2011: Therapist as operator or interactor? Moving beyond the technique. Journal of Manual and Manipulative Therapy 19(2): 120-121

Pulford, J.; Adams, P.; Sheridan, J. 2008: Therapist attitudes and beliefs relevant to client dropout revisited. Community Mental Health Journal 44(3): 181-186

Hedberg-Kristensson, E.; Iwarsson, S. 2013: Therapist attitudes and strategies to client-centred approaches in the provision of mobility devices to older clients. Disability and Rehabilitation. Assistive Technology 8(5): 381-386

Becker, E.M.; Jensen-Doss, A. 2014: Therapist attitudes towards computer-based trainings. Administration and Policy in Mental Health 41(6): 845-854

Moulden, H.M.; Firestone, P. 2010: Therapist awareness and responsibility in working with sexual offenders. Sexual Abuse: a Journal of Research and Treatment 22(4): 374-386

Foster, S.L.; Cunningham, P.B.; Warner, S.E.; McCoy, D.M.; Barr, T.S.; Henggeler, S.W. 2009: Therapist behavior as a predictor of black and white caregiver responsiveness in multisystemic therapy. Journal of Family Psychology: Jfp: Journal of the Division of Family Psychology of the American Psychological Association 23(5): 626-635

Paxling, Börn.; Lundgren, S.; Norman, A.; Almlöv, J.; Carlbring, P.; Cuijpers, P.; Andersson, G. 2013: Therapist behaviours in internet-delivered cognitive behaviour therapy: analyses of e-mail correspondence in the treatment of generalized anxiety disorder. Behavioural and Cognitive PsychoTherapy 41(3): 280-289

Hersoug, A.G.; Høglend, P.; Havik, O.; von der Lippe, A.; Monsen, J. 2009: Therapist characteristics influencing the quality of alliance in long-term psychotherapy. Clinical Psychology and PsychoTherapy 16(2): 100-110

Peters-Scheffer, N.; Didden, R.; Korzilius, H.; Sturmey, P. 2013: Therapist characteristics predict discrete trial teaching procedural fidelity. Intellectual and Developmental Disabilities 51(4): 263-272

Sánchez-Bahíllo, Án.; Aragón-Alonso, A.; Sánchez-Bahíllo, M.ía.; Birtle, J. 2014: Therapist characteristics that predict the outcome of multipatient psychotherapy: systematic review of empirical studies. Journal of Psychiatric Research 53: 149-156

Strunk, D.R.; Brotman, M.A.; DeRubeis, R.J.; Hollon, S.D. 2010: Therapist competence in cognitive therapy for depression: predicting subsequent symptom change. Journal of Consulting and Clinical Psychology 78(3): 429-437

Kuyken, W.; Tsivrikos, D. 2009: Therapist competence, comorbidity and cognitive-behavioral therapy for depression. PsychoTherapy and Psychosomatics 78(1): 42-48

Fairburn, C.G.; Cooper, Z. 2011: Therapist competence, therapy quality, and therapist training. Behaviour Research and Therapy 49(6-7): 373-378

Tripathi, R.; Bharath, S.; Desai, G.; Mehrotra, S. 2013: Therapist concerns and process issues in grappling with functional autobiographical amnesia. Indian Journal of Psychological Medicine 35(3): 305-308

Hayes, J.A.; Owen, J.; Bieschke, K.J. 2015: Therapist differences in symptom change with racial/ethnic minority clients. PsychoTherapy 52(3): 308-314

Koch, R.L. 2007: Therapist driven protocols: a look back and moving into the future. Critical Care Clinics 23(2): 149-159 VII-VIII

Kraus, D.R.; Castonguay, L.; Boswell, J.F.; Nordberg, S.S.; Hayes, J.A. 2011: Therapist effectiveness: implications for accountability and patient care. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 21(3): 267-276

Green, H.; Barkham, M.; Kellett, S.; Saxon, D. 2014: Therapist effects and IAPT Psychological Wellbeing Practitioners (PWPs): a multilevel modelling and mixed methods analysis. Behaviour Research and Therapy 63: 43-54

Wiborg, J.F.; Knoop, H.; Wensing, M.; Bleijenberg, G. 2012: Therapist effects and the dissemination of cognitive behavior therapy for chronic fatigue syndrome in community-based mental health care. Behaviour Research and Therapy 50(6): 393-396

Huppert, J.D.; Kivity, Y.; Barlow, D.H.; Gorman, J.M.; Shear, M.K.; Woods, S.W. 2014: Therapist effects and the outcome-alliance correlation in cognitive behavioral therapy for panic disorder with agoraphobia. Behaviour Research and Therapy 52: 26-34

Almlöv, J.; Carlbring, P.; Källqvist, K.; Paxling, B.ör.; Cuijpers, P.; Andersson, G. 2011: Therapist effects in guided internet-delivered CBT for anxiety disorders. Behavioural and Cognitive PsychoTherapy 39(3): 311-322

Walters, S.J. 2010: Therapist effects in randomised controlled trials: what to do about them. Journal of Clinical Nursing 19(7-8): 1102-1112

Cella, M.; Stahl, D.; Reme, S.Endresen.; Chalder, T. 2011: Therapist effects in routine psychotherapy practice: an account from chronic fatigue syndrome. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 21(2): 168-178

Huete, J.M.; Kurtz, P.F. 2010: Therapist effects on functional analysis outcomes with young children. Research in Developmental Disabilities 31(3): 804-810

Dinger, U.; Strack, M.; Leichsenring, F.; Wilmers, F.; Schauenburg, H. 2008: Therapist effects on outcome and alliance in inpatient psychotherapy. Journal of Clinical Psychology 64(3): 344-354

Davis, T.A.; Ancis, J.R.; Ashby, J.S. 2015: Therapist effects, working alliance, and African American women substance users. Cultural Diversity and Ethnic Minority Psychology 21(1): 126-135

Anderson, T.; Ogles, B.M.; Patterson, C.L.; Lambert, M.J.; Vermeersch, D.A. 2009: Therapist effects: facilitative interpersonal skills as a predictor of therapist success. Journal of Clinical Psychology 65(7): 755-768

Westra, H.A.; Aviram, A.; Connors, L.; Kertes, A.; Ahmed, M. 2012: Therapist emotional reactions and client resistance in cognitive behavioral therapy. PsychoTherapy 49(2): 163-172

Angus, L.E.; Kagan, F. 2009: Therapist empathy and client anxiety reduction in motivational interviewing: "She carries with me, the experience". Journal of Clinical Psychology 65(11): 1156-1167

Rubino, G.; Barker, C.; Roth, T.; Fearon, P. 2000: Therapist empathy and depth of interpretation in response to potential alliance ruptures: the role of therapist and patient attachment styles. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 10(4): 408-420

Andersson, G.; Carlbring, P.; Furmark, T.; Furmark, T.; Andersson, G.; Carlbring, P.; Ekselius, L.; Felix, C.B.; Lundborg, L.; Rosenström, A.; Josserand, J.; Larm, K.; Gunnarsson, L.S.öv.; Hammer, S.; Wahlgren, I.; Lynch, C.O.; Sundling, K.; Engdahl, S.; Gustafsson, S.; Ersson, A.-S.; Grut, E.; Almöv, J.; Linna, E.; Maurin, L.; Törngren, C.; Bjärehed, J.; Dahlin, M.; Malmeus, F. 2012: Therapist experience and knowledge acquisition in internet-delivered CBT for social anxiety disorder: a randomized controlled trial. Plos one 7(5): E37411

Almlöv, J.; Carlbring, P.; Berger, T.; Cuijpers, P.; Andersson, G. 2009: Therapist factors in Internet-delivered cognitive behavioural therapy for major depressive disorder. Cognitive Behaviour Therapy 38(4): 247-254

Long, M.E.; Grubaugh, A.L.; Elhai, J.D.; Cusack, K.J.; Knapp, R.; Frueh, B.C. 2010: Therapist fidelity with an exposure-based treatment of PTSD in adults with schizophrenia or schizoaffective disorder. Journal of Clinical Psychology 66(4): 383-393

Magill, M.; Stout, R.L.; Apodaca, T.R. 2013: Therapist focus on ambivalence and commitment: a longitudinal analysis of Motivational Interviewing treatment ingredients. Psychology of Addictive Behaviors: Journal of the Society of Psychologists in Addictive Behaviors 27(3): 754-762

Hedman, E. 2014: Therapist guided internet delivered cognitive behavioural therapy. Bmj 348: G1977

Kasper, L.B.; Hill, C.E.; Kivlighan, D.M. 2008: Therapist immediacy in brief psychotherapy: Case study I. PsychoTherapy 45(3): 281-297

Hill, C.E.; Sim, W.; Spangler, P.; Stahl, J.; Sullivan, C.; Teyber, E. 2008: Therapist immediacy in brief psychotherapy: Case study II. PsychoTherapy 45(3): 298-315

Cunha, C.; Gonçalves, M.M.; Hill, C.E.; Mendes, I.ês.; Ribeiro, A.ón.P.; Sousa, I.ês.; Angus, L.; Greenberg, L.S. 2012: Therapist interventions and client innovative moments in emotion-focused therapy for depression. PsychoTherapy 49(4): 536-548

Hendriksen, M.ël.; Van, H.L.; Schoevers, R.A.; de Jonghe, F.E.R.E.R.; Gijsbers van Wijk, C.M.T.; Peen, J.; Dekker, J.J.M. 2011: Therapist judgment of defense styles and therapeutic technique related to outcome in psychodynamic psychotherapy for depression. PsychoTherapy and Psychosomatics 80(6): 377-379

Hendrick, P.; Mani, R.; Bishop, A.; Milosavljevic, S.; Schneiders, A.G. 2013: Therapist knowledge, adherence and use of low back pain guidelines to inform clinical decisions--a national survey of manipulative and sports physiotherapists in New Zealand. Manual Therapy 18(2): 136-142

Fuertes, J.N.; Stracuzzi, T.I.; Bennett, J.; Scheinholtz, J.; Mislowack, A.; Hersh, M.; Cheng, D. 2006: Therapist multicultural competency: a study of therapy dyads. PsychoTherapy 43(4): 480-490

Spangler, P.; Hill, C.E.; Mettus, C.; Guo, A.Huajing.; Heymsfield, L. 2009: Therapist perspectives on their dreams about clients: a qualitative investigation. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 19(1): 81-95

Nissen-Lie, H.A.; Monsen, J.Trygve.; Rønnestad, M.Helge. 2010: Therapist predictors of early patient-rated working alliance: a multilevel approach. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 20(6): 627-646

Campbell, B.K.; Buti, A.; Fussell, H.E.; Srikanth, P.; McCarty, D.; Guydish, J.R. 2013: Therapist predictors of treatment delivery fidelity in a community-based trial of 12-step facilitation. American Journal of Drug and Alcohol Abuse 39(5): 304-311

Furrow, J.L.; Edwards, S.A.; Choi, Y.; Bradley, B. 2012: Therapist presence in emotionally focused couple therapy blamer softening events: promoting change through emotional experience. Journal of Marital and Family Therapy 38 Suppl. 1: 39-49

Burckell, L.A.; Goldfried, M.R. 2006: Therapist qualities preferred by sexual-minority individuals. PsychoTherapy 43(1): 32-49

Melendez-Calderon, A.; Piovesan, D.; Mussa-Ivaldi, F.A. 2013: Therapist recognition of impaired muscle groups in simulated multi-joint hypertonia. IEEE . International Conference on Rehabilitation Robotics: 2013: 6650425

Elkin, I.; Falconnier, L.; Smith, Y.; Canada, K.E.; Henderson, E.; Brown, E.R.; McKay, B.M. 2014: Therapist responsiveness and patient engagement in therapy. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 24(1): 52-66

Chu, B.C.; Kendall, P.C. 2009: Therapist responsiveness to child engagement: flexibility within manual-based CBT for anxious youth. Journal of Clinical Psychology 65(7): 736-754

Jungbluth, N.J.; Shirk, S.R. 2009: Therapist strategies for building involvement in cognitive-behavioral therapy for adolescent depression. Journal of Consulting and Clinical Psychology 77(6): 1179-1184

Briggs, D.B.; Munley, P.H. 2008: Therapist stress, coping, career sustaining behavior and the working alliance. Psychological Reports 103(2): 443-454

Valdes, K.; Naughton, N.; Michlovitz, S. 2014: Therapist supervised clinic-based therapy versus instruction in a home program following distal radius fracture: a systematic review. Journal of Hand Therapy: Official Journal of the American Society of Hand Therapists 27(3): 165-73; Quiz 174

Drapeau, M.; de Roten, Y.; Beretta, V.ér.; Blake, E.; Koerner, A.; Despland, J.-N. 2008: Therapist technique and patient defensive functioning in ultra-brief psychodynamic psychotherapy: a Lag sequential analysis. Clinical Psychology and PsychoTherapy 15(4): 247-255

Roth, A.D.; Pilling, S.; Turner, J. 2010: Therapist training and supervision in clinical trials: implications for clinical practice. Behavioural and Cognitive PsychoTherapy 38(3): 291-302

Decker, S.E.; Jameson, M.T.; Naugle, A.E. 2011: Therapist training in empirically supported treatments: a review of evaluation methods for short- and long-term outcomes. Administration and Policy in Mental Health 38(4): 254-286

Crook-Lyon, R.E.; Hill, C.E.; Wimmer, C.L.; Hess, S.A.; Goates-Jones, M.K. 2009: Therapist training, feedback, and practice for dream work: a pilot study. Psychological Reports 105(1): 87-98

Glisson, C.; Schoenwald, S.K.; Kelleher, K.; Landsverk, J.; Hoagwood, K.Eaton.; Mayberg, S.; Green, P. 2008: Therapist turnover and new program sustainability in mental health clinics as a function of organizational culture, climate, and service structure. Administration and Policy in Mental Health 35(1-2): 124-133

Walwyn, R.; Roberts, C. 2010: Therapist variation within randomised trials of psychotherapy: implications for precision, internal and external validity. Statistical Methods in Medical Research 19(3): 291-315

Artkoski, T.; Saarnio, P. 2013: Therapist's Gender and Gender Roles: Impact on Attitudes toward Clients in Substance Abuse Treatment. Journal of Addiction 2013: 591521

Nivoli, A.M.A.; Nivoli, F.L.G.; Nivoli, G.C.; Lorettu, L. 2011: Therapist's reactions on the treatment of suicidal patients. Rivista di Psichiatria 46(1): 57-65

Baker-Ericzén, M.J.; Jenkins, M.M.; Haine-Schlagel, R. 2013: Therapist, Parent, and Youth Perspectives of Treatment Barriers to Family-Focused Community Outpatient Mental Health Services. Journal of Child and Family Studies 22(6): 854-868

Tiger, J.H.; Fisher, W.W.; Bouxsein, K.J. 2009: Therapist- and self-monitored DRO contingencies as a treatment for the self-injurious skin picking of a young man with Asperger syndrome. Journal of Applied Behavior Analysis 42(2): 315-319

Ter Kuile, M.M.; Melles, R.; de Groot, H.E.; Tuijnman-Raasveld, C.C.; van Lankveld, J.J.D.M. 2013: Therapist-aided exposure for women with lifelong vaginismus: a randomized waiting-list control trial of efficacy. Journal of Consulting and Clinical Psychology 81(6): 1127-1136

Ter Kuile, M.M.; Bulté, I.; Weijenborg, P.T.M.; Beekman, A.; Melles, R.; Onghena, P. 2009: Therapist-aided exposure for women with lifelong vaginismus: a replicated single-case design. Journal of Consulting and Clinical Psychology 77(1): 149-159

Shandley, K.; Austin, D.W.; Klein, B.; Pier, C.; Schattner, P.; Pierce, D.; Wade, V. 2008: Therapist-assisted, Internet-based treatment for panic disorder: can general practitioners achieve comparable patient outcomes to psychologists?. Journal of Medical Internet Research 10(2): E14

Hahlweg, K.; Heinrichs, N.; Kuschel, A.; Feldmann, M. 2008: Therapist-assisted, self-administered bibliotherapy to enhance parental competence: short- and long-term effects. Behavior Modification 32(5): 659-681

Kessler, D.; Lewis, G.; Kaur, S.; Wiles, N.; King, M.; Weich, S.; Sharp, D.J.; Araya, R.; Hollinghurst, S.; Peters, T.J. 2009: Therapist-delivered Internet psychotherapy for depression in primary care: a randomised controlled trial. Lancet 374(9690): 628-634

Enander, J.; Ivanov, V.Z.; Andersson, E.; Mataix-Cols, D.; Ljótsson, B.án.; Rück, C. 2014: Therapist-guided, Internet-based cognitive-behavioural therapy for body dysmorphic disorder (BDD-NET): a feasibility study. Bmj Open 4(9): E005923

Klein, H. 1992: Therapist-initiated patient transfer in the residency training setting. Academic Psychiatry: the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 16(1): 37-43

Rozario, S.V.; Housman, S.; Kovic, M.; Kenyon, R.V.; Patton, J.L. 2009: Therapist-mediated post-stroke rehabilitation using haptic/graphic error augmentation. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2009: 1151-1156

Driessen, E.; Van Henricus, L.; Peen, J.; Don, F.J.; Kool, S.; Westra, D.; Hendriksen, M.ël.; Cuijpers, P.; Twisk, J.W.R.; Dekker, J.J.M. 2015: Therapist-rated outcomes in a randomized clinical trial comparing cognitive behavioral therapy and psychodynamic therapy for major depression. Journal of Affective Disorders 170: 112-118

Blow, A.J.; Davis, S.D.; Sprenkle, D.H. 2012: Therapist-worldview matching: not as important as matching to clients. Journal of Marital and Family Therapy 38(Suppl 1): 13-17

Garland, A.F.; Brookman-Frazee, L. 2015: Therapists and researchers: advancing collaboration. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 25(1): 95-107

Ruskin, A. 2007: Therapists at center stage. Rehab Management 20(8): 40

Simonenko, V.B. 2010: Therapists during the Great Patriotic War. Klinicheskaia Meditsina 88(3): 4-7

Staudt, M.; Lodato, G.; Hickman, C.R. 2012: Therapists talk about the engagement process. Community Mental Health Journal 48(2): 212-218

Bourke, M.E.; Grenyer, B.F.S. 2013: Therapists' accounts of psychotherapy process associated with treating patients with borderline personality disorder. Journal of Personality Disorders 27(6): 735-745

Coutinho, J.; Ribeiro, E.; Hill, C.; Safran, J. 2011: Therapists' and clients' experiences of alliance ruptures: a qualitative study. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 21(5): 525-540

Apte, A.; Kielhofner, G.; Paul-Ward, A.; Braveman, B. 2005: Therapists' and clients' perceptions of the occupational performance history interview. Occupational Therapy in Health Care 19(1-2): 173-192

Levitt, H.M.; Piazza-Bonin, E. 2011: Therapists' and clients' significant experiences underlying psychotherapy discourse. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 21(1): 70-85

Hertlein, K.M.; Piercy, F.P. 2008: Therapists' assessment and treatment of internet infidelity cases. Journal of Marital and Family Therapy 34(4): 481-497

Dinger, U.; Strack, M.; Sachsse, T.; Schauenburg, H. 2009: Therapists' attachment, patients' interpersonal problems and alliance development over time in inpatient psychotherapy. PsychoTherapy 46(3): 277-290

Nelson, M.M.; Shanley, J.R.; Funderburk, B.W.; Bard, E. 2012: Therapists' attitudes toward evidence-based practices and implementation of parent-child interaction therapy. Child Maltreatment 17(1): 47-55

Brookman-Frazee, L.; Garland, A.F.; Taylor, R.; Zoffness, R. 2009: Therapists' attitudes towards psychotherapeutic strategies in community-based psychotherapy with children with disruptive behavior problems. Administration and Policy in Mental Health 36(1): 1-12

Murdock, N.L.; Edwards, C.; Murdock, T.B. 2010: Therapists' attributions for client premature termination: are they self-serving?. PsychoTherapy 47(2): 221-234

Hoffart, A.; Friis, S. 2000: Therapists' emotional reactions to anxious inpatients during integrated behavioral-psychodynamic treatment: a psychometric evaluation of a feeling word checklist. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 10(4): 462-473

Kouriatis, K.; Brown, D. 2013: Therapists' experience of loss: an interpretative phenomenological analysis. Omega 68(2): 89-109

Suddick, K.M.; De Souza, L.H. 2007: Therapists' experiences and perceptions of teamwork in neurological rehabilitation: critical happenings in effective and ineffective teamwork. Journal of Interprofessional Care 21(6): 669-686

Roubal, J.; Rihacek, T. 2016: Therapists' in-session experiences with depressive clients: A grounded theory. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 26(2): 206-219

Segal, R.; Bhatia, M.; Drapeau, M. 2011: Therapists' perception of benefits and costs of using virtual reality treatments. Cyberpsychology Behavior and Social Networking 14(1-2): 29-34

Heinonen, E.; Knekt, P.; Jääskeläinen, T.; Lindfors, O. 2014: Therapists' professional and personal characteristics as predictors of outcome in long-term psychodynamic psychotherapy and psychoanalysis. European Psychiatry: the Journal of the Association of European Psychiatrists 29(5): 265-274

Heinonen, E.; Lindfors, O.; Laaksonen, M.A.; Knekt, P. 2012: Therapists' professional and personal characteristics as predictors of outcome in short- and long-term psychotherapy. Journal of Affective Disorders 138(3): 301-312

Hamilton, J.; Kivlighan, D.M. 2009: Therapists' projection: the effects of therapists' relationship themes on their formulation of clients' relationship episodes. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 19(3): 312-322

Blasko, K.A.; Winek, J.L.; Bieschke, K.J. 2007: Therapists' prototypical assessment of domestic violence situations. Journal of Marital and Family Therapy 33(2): 258-269

Thompson, V.L.Sanders.; Alexander, H. 2006: Therapists' race and African American clients' reactions to therapy. PsychoTherapy 43(1): 99-110

Markowitz, J.C.; Manber, R.; Rosen, P. 2008: Therapists' responses to training in brief supportive psychotherapy. American Journal of PsychoTherapy 62(1): 67-81

Guihan, M.; Hastings, J.; Garber, S.L. 2009: Therapists' roles in pressure ulcer management in persons with spinal cord injury. Journal of Spinal Cord Medicine 32(5): 560-567

Boterhoven De Haan, K.L.; Lee, C.W. 2014: Therapists' thoughts on therapy: clinicians' perceptions of the therapy processes that distinguish schema, cognitive behavioural and psychodynamic approaches. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 24(5): 538-549

Connell, L.A.; McMahon, N.E.; Watkins, C.L.; Eng, J.J. 2014: Therapists' use of the Graded Repetitive Arm Supplementary Program (GRASP) intervention: a practice implementation survey study. Physical Therapy 94(5): 632-643

Froján, M.X.ús.; Montaño, M.; Calero, A. 2010: Therapists' verbal behavior analysis: a descriptive approach to the psychotherapeutic phenomenon. Spanish Journal of Psychology 13(2): 914-926

Froján Parga, M.ía.X.ús.; Montaño Fidalgo, M.; Calero Elvira, A.; García Soler, A.; Garzón Fernández, A.; Ruiz Sancho, E.M.ía. 2008: Therapists' verbal behavior category system. Psicothema 20(4): 603-609

Lilliengen, P.; Werbart, A. 2010: Therapists' view of therapeutic action in psychoanalytic psychotherapy with young adults. PsychoTherapy 47(4): 570-585

Mäkelä, J.; Salo, S. 2011: Theraplay--interactive therapy between parent and child in juvenile mental problems. Duodecim; Laaketieteellinen Aikakauskirja 127(4): 327-334

Hernández Guerrero, A.él.; Sobrino Cossio, S. 2005: Therapuetic colonoscopy. Revista de Gastroenterologia de Mexico 70(Suppl 1): 149-157

Yilmaz, T.; Jiffar, T.; de la Garza, G.; Lin, H.; Milas, Z.; Takahashi, Y.; Hanna, E.; MacIntyre, T.; Brown, J.L.; Myers, J.N.; Kupferman, M.E. 2010: Theraputic targeting of Trk supresses tumor proliferation and enhances cisplatin activity in HNSCC. Cancer Biology and Therapy 10(6): 644-653

Aboul-Fotouh, F.; Asghar-Ali, A.A. 2010: Therapy 101: a psychotherapy curriculum for medical students. Academic Psychiatry: the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 34(4): 248-252

Arai, R. 2010: Therapy Adherence in Crohn's Disease: An Adult Case Study. Case Reports in Gastroenterology 4(2): 153-157

Ghrarami, R.C. 2000: Therapy for an Extensive Childhood Vitiligo (le). Indian Journal of Dermatology Venereology and Leprology 66(3): 161

Kersting, C.; Lindemann, C.; Jacobi, C.; Lo Baido, A.; Schneider, A.; Yurdakul, M.; Ziegler-Kirbach, E.; Mikolajczyk, R.; Garbe, E. 2016: Therapy Goals for Children and Adolescents with ADHD and their Primary Caregivers. a Content Analysis and Examination of Agreement of ADHD Patients and their Primary Caregivers. Gesundheitswesen 78(1): 34-36

Anonymous 1909: Therapy of Meningitis. California state journal of medicine 7(9): 312

Simpson, B.T.; Marsh, M.C. 1931: Therapy of Spontaneous Mouse Cancer: Failure of Tuberculin, Karkinolysin, and some Inorganic Compounds Therein. Annals of Surgery 93(1): 169-179

Barrett, H.H.; Wilson, D.W.; Kupinski, M.A.; Aguwa, K.; Ewell, L.; Hunter, R.; Müller, S. 2010: Therapy Operating Characteristic (TOC) Curves and their Application to the Evaluation of Segmentation Algorithms. Proceedings of Spie--the International Society for Optical Engineering 7627: 76270z

Olaniyi, J.A.; Oluwasola, A.O.; Ibijola, A. 2011: Therapy Outcome of a T-Cell-Rich-B-Cell Lymphoma (TCRBCL) Patient with R-CHOP in Ibadan, Nigeria: a Case Report. Mediterranean Journal of Hematology and Infectious Diseases 3(1): E2011008

Schiepek, Günter.; Aichhorn, W.; Strunk, G. 2012: Therapy Process Questionnaire (TPQ) - a combined explorative and confirmatory factor analysis and psychometric properties. Zeitschrift für Psychosomatische Medizin und Psychotherapie 58(3): 257-266

Pabst, S.; Hammerstingl, C.; Nickenig, G.; Skowasch, D. 2010: Therapy according to current guidelines. Practical management of pulmonary arterial hypertension.. Pharmazie in Unserer Zeit 39(6): 448-452

Neumann, F.; Markett, J.; Fenk, R.; Pooten, M.; Koch, A.; Bruennert, D.; Schimkus, N.; Wulfert, M.; Royer-Pokora, B.; Kronenwett, R.; Haas, R.; Gattermann, N. 2008: Therapy adapted to molecular response in patients with chronic myelogenous leukaemia in first chronic phase: results of the Duesseldorf study. Hematological Oncology 26(4): 213-218

Grosset, D. 2010: Therapy adherence issues in Parkinson's disease. Journal of the Neurological Sciences 289(1-2): 115-118

López-Méndez, P.; Río, J.; Pérez-Ricart, A.; Tintoré, M.; Sastre-Garriga, J.; Cardona-Pascual, I.; Gómez-Domingo, M.R.; Montalban, X. 2013: Therapy adherence to immunomodulator treatment in patients with multiple sclerosis. Revista de Neurologia 56(1): 8-12

Dorf, E.; Blue, C.; Smith, B.P.; Koman, L.A. 2010: Therapy after injury to the hand. Journal of the American Academy of Orthopaedic Surgeons 18(8): 464-473

Straube, A.; Gaul, C.; Förderreuther, S.; Kropp, P.; Marziniak, M.; Evers, S.; Jost, W.H.; Göbel, H.; Lampl, C.; Sándor, P.S.; Gantenbein, A.R.; Diener, H-C. 2012: Therapy and care of patients with chronic migraine: expert recommendations of the German Migraine and Headache Society/German Society for Neurology as well as the Austrian Headache Society/Swiss Headache Society. Der Nervenarzt 83(12): 1600-1608

Skrygin, V.P. 1949: Therapy and classification of scoliosis. Trudy. Tsentral'nyi Nauchno-Issledovatel'skii Institut Protezirovaniia i Protezostroeniia 3: 47-70

Duttaroy, A.K. 2007: Therapy and clinical trials. Current Opinion in Lipidology 18(3): 384-386

Jialal, I.; Devaraj, S. 2007: Therapy and clinical trials. Current Opinion in Lipidology 18(4): 479-481

Duttaroy, A.K.; Ray, T.K. 2008: Therapy and clinical trials. Current Opinion in Lipidology 19(3): 330-332

Krasuski, R.A. 2008: Therapy and clinical trials. Current Opinion in Lipidology 19(5): 550-551

Depta, J.P.; Krasuski, R.A. 2009: Therapy and clinical trials. Current Opinion in Lipidology 20(3): 262-263

Devendra, G.P.; Krasuski, R.A. 2010: Therapy and clinical trials. Current Opinion in Lipidology 21(5): 471-472

Elmallah, W.; Krasuski, R.A. 2011: Therapy and clinical trials. Current Opinion in Lipidology 22(6): 512-513

Sodhi, N.; Krasuski, R.A. 2013: Therapy and clinical trials. Current Opinion in Lipidology 24(3): 281-282

Udiawar, M.V.; Rees, A. 2009: Therapy and clinical trials: Familial hypercholesterolaemia and prevention of coronary artery disease. Current Opinion in Lipidology 20(5): 450-451

Virani, S.S.; Ballantyne, C.M. 2010: Therapy and clinical trials: HDL-cholesterol and niacin therapy--past, present, and future. Current Opinion in Lipidology 21(2): 165-166

Catapano, A.L.; Norata, G.D.; Pirillo, A. 2011: Therapy and clinical trials: aggressive statin therapy versus combined and emerging approaches. Current Opinion in Lipidology 22(4): 324-325

Peter, R. 2008: Therapy and clinical trials: diabetes and cardiovascular risk. Current Opinion in Lipidology 19(1): 101-103

Peter, R.; Reilly, E.; Anthony, S. 2010: Therapy and clinical trials: fibrate therapy in type 2 diabetes - where are we now?. Current Opinion in Lipidology 21(6): 554-555

Bolusani, H.; Peter, R.; Rees, A. 2008: Therapy and clinical trials: glycaemia and prevention of macroangiopathy in type 2 diabetes. Current Opinion in Lipidology 19(6): 629-630

Edavalath, M.; Rees, A. 2009: Therapy and clinical trials: glycaemic control and cardiovascular disease. Current Opinion in Lipidology 20(6): 530-531

Jialal, I.; Bajaj, M. 2009: Therapy and clinical trials: management of diabetic dyslipidemia. Current Opinion in Lipidology 20(1): 85-86

Edavalath, M.; Rees, A. 2008: Therapy and clinical trials: metabolic syndrome and cardiovascular risk management. Current Opinion in Lipidology 19(4): 438-439

Pellegatta, F.; Grigore, L.; Catapano, A.L. 2010: Therapy and clinical trials: new insights. Current Opinion in Lipidology 21(4): 394-395

Udiawar, M.V.; Rees, A. 2010: Therapy and clinical trials: nicotinic acid in the management of atherosclerotic disease. Current Opinion in Lipidology 21(3): 286-288

Aizawa, Y. 2011: Therapy and concept of the antiarrhythmic drugs in patients with ischemic heart disease. Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 9): 486-493

Laleman, W.; Verreth, A. 2014: Therapy and follow-up for ampullary adenomas: one size clearly does not fit all, although we ought to keep trying in clinical practice. Surgical Endoscopy 28(7): 2252-2253

Meyer, D.; Schmid, H.-P.; Engeler, D.S. 2007: Therapy and follow-up of bladder cancer. Wiener Medizinische Wochenschrift 157(7-8): 162-169

Rolnik, E.J.; Freud, S.; Einstein, A. 2010: Therapy and ideology: psychoanalysis and its vicissitudes in pre-state Israel (including some hitherto unpublished letters by Sigmund Freud and Albert Einstein). Science in Context 23(4): 473-506

Smee, D.F.; Wong, M.-H.; Russell, A.; Ennis, J.; Turner, J.D. 2011: Therapy and long-term prophylaxis of vaccinia virus respiratory infections in mice with an adenovirus-vectored interferon alpha (mDEF201). Plos one 6(10): E26330

Bakhshi, S.; Meel, R.; Naqvi, S.G.H.; Mohanti, B.K.; Kashyap, S.; Pushker, N.; Sen, S. 2009: Therapy and outcome of orbital primitive neuroectodermal tumor. Pediatric Blood and Cancer 52(4): 544-547

Bakhshi, S.; Pathania, S.; Mohanti, B.K.; Thulkar, S.; Thakar, A. 2011: Therapy and outcome of primitive neuroectodermal tumor of the jaw. Pediatric Blood and Cancer 56(3): 477-481

Loftin, E.G.; Herold, L.V. 2009: Therapy and outcome of suspected alpha lipoic acid toxicity in two dogs. Journal of Veterinary Emergency and Critical Care 19(5): 501-506

Suzuki, N. 2008: Therapy and prevention of cardiogenic cerebral embolism. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 97(3): 570-574

Bartl, R. 2012: Therapy and prevention of fracture pain in osteoporosis. MMW Fortschritte der Medizin 154(6): 73-76

Suttorp, N.; Endres, S. 2014: Therapy and prevention of infectious diseases. Drug Research 64 Suppl. 1: S1

Zhang, S.-S.; Wei, M.; Li, H.-H.; Jing, Y.; Li, F.; Huang, W.-R.; Lu, X.-L.; Liu, Z.-X.; Zhou, Y.; Yu, L. 2011: Therapy and prognosis analysis of 47 patients with extranodal NK/T-cell lymphoma. Zhongguo Shi Yan Xue Ye Xue Za Zhi 19(1): 119-123

Hosoya, M. 2007: Therapy and prognosis in subacute sclerosing panencephalitis. Nihon Rinsho. Japanese Journal of Clinical Medicine 65(8): 1483-1486

Kämmerer, P.W.; Shabazfar, N.; Palarie, V.; Kleis, W.; Al-Nawas, B. 2011: Therapy and prognosis of extraoral malignant melanoma metastasizing to the jaw: case report and literature review. Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons 69(4): 1229-1234

Jiang, G.-Y.; Li, F.-C.; Chen, W.-K.; Liu, A.-M.; Cai, W.-Q. 2011: Therapy and prognosis of intracranial invasive olfactory neuroblastoma. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 145(6): 951-955

Muso, E. 2014: Therapy and prognosis of medium and small vessel vasculitis. Nihon Jinzo Gakkai Shi 56(2): 105-116

Siedek, V.; Zengel, P.; Berghaus, A. 2008: Therapy and prognosis of xerostomia. MMW Fortschritte der Medizin 150(5): 31-33

Ji, S.-P.; Li, Q.; Dong, H. 2010: Therapy and prognostic features of primary clear cell carcinoma of the liver. World Journal of Gastroenterology 16(6): 764-769

Kienast, Y.; Winkler, F. 2010: Therapy and prophylaxis of brain metastases. Expert Review of Anticancer Therapy 10(11): 1763-1777

Plicht, B.; Naber, C.K.; Erbel, R. 2008: Therapy and prophylaxis of infective endocarditis. Der Internist 49(10): 1219-1227; Quiz: 1228-1229

Hoffmann, J.; Reuter, U. 2009: Therapy and prophylaxis of migraine. MMW Fortschritte der Medizin 151(14): 114-117; Quiz 118

Thoden, J.; Potthoff, A.; Bogner, J.R.; Brockmeyer, N.H.; Esser, S.; Grabmeier-Pfistershammer, K.; Haas, B.; Hahn, K.; Härter, G.; Hartmann, M.; Herzmann, C.; Hutterer, J.; Jordan, A.R.; Lange, C.; Mauss, S.; Meyer-Olson, D.; Mosthaf, F.; Oette, M.; Reuter, S.; Rieger, A.; Rosenkranz, T.; Ruhnke, M.; Schaaf, B.; Schwarze, S.; Stellbrink, H.J.; Stocker, H.; Stoehr, A.; Stoll, M.; Träder, C.; Vogel, M.; Wagner, D.; Wyen, C.; Hoffmann, C. 2013: Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066). Infection 41 Suppl. 2: S91-115

Pesek, M.B. 2009: Therapy and quality of life of patients with psychosis. Psychiatria Danubina 21(Suppl 1): 146-148

Prasong, T. 1966: Therapy and therapeutic studies of Thai haemorrhagic fever. Bulletin of the World Health Organization 35(1): 74

Schmitz-Valckenberg, S.; Mössner, A.; Fleckenstein, M.; Wiedemann, P.; Holz, F.G. 2010: Therapy approaches for geographic atrophy. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 107(11): 1016-1019

Khrustalev, I.M. 2008: Therapy as a base of national health promotion. Issues of medical ethics. Terapevticheskii Arkhiv 80(8): 78-80

Di Rezze, B.; Law, M.; Eva, K.; Pollock, N.; Gorter, J.Willem. 2014: Therapy behaviours in paediatric rehabilitation: essential attributes for intervention with children with physical disabilities. Disability and Rehabilitation 36(1): 16-22

Ishii, K.; Hayashi, S.; Mabuchi, A.; Taguchi, T.; Yamamoto, R.; Murata, M.; Mitsuda, N. 2014: Therapy by laser equatorial placental dichorionization for early-onset spontaneous twin anemia-polycythemia sequence. Fetal Diagnosis and Therapy 35(1): 65-68

Microys, G.I. 1978: Therapy can be fun. Canadian Family Physician Medecin de Famille Canadien 24: 866-869

Lee, M.C.; Bhati, R.S.; von Rottenthaler, E.E.; Reagan, A.M.; Karver, S.B.; Reich, R.R.; Quinn, G.P. 2013: Therapy choices and quality of life in young breast cancer survivors: a short-term follow-up. American Journal of Surgery 206(5): 625-631

Gillitzer, R.; Hampel, C.; Thomas, C.; Schmidt, F.; Melchior, S.W.; Pahernik, S.; Schmidberger, H.; Thüroff, J.W. 2009: Therapy choices of German urologists and radio-oncologists if personally diagnosed with localized prostate cancer. Der Urologe. Ausg. a 48(4): 399-407

Márquez Contreras, E.; Casado Martínez, Jé.Joaquín.; Motero Carrasco, J.; Martín de Pablos, Jé.Luis.; Chaves González, R.; Losada Ruiz, C.; Pastoriza Vilas, Jé.Carlos. 2007: Therapy compliance in cases of hyperlipaemia, as measured through electronic monitors. Is a reminder calendar to avoid forgetfulness effective?. Atencion primaria 39(12): 661-668

Sabourin, G. 2014: Therapy compliance. Best when drug is prescribed long term. Perspective Infirmiere: Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 11(2): 60-61

Von Minckwitz, G. 2002: Therapy concept: herceptin in combination with arimidex. Onkologie 25(Suppl 5): 22 ; Discussion: 22-24

Untch, M. 2002: Therapy concept: herceptin with anthracyclines. Onkologie 25(Suppl 5): 19-21; Discussion 21

Wang, L. 2013: Therapy conception and thinking of proximal humeral fractures. Zhongguo Gu Shang 26(1): 1-3

Wildenauer, R.; Germer, C.T. 2010: Therapy concepts for septic diseases. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 81(5): 477-8; Author Reply 478-9

Niedermeyer, M. 2012: Therapy consultation--motivating the patient to change his behavior. Zentralblatt für Chirurgie 137(3): 207-208

Bendall, S.; Allott, K.; Jovev, M.; Marois, M.-J.; Killackey, E.J.; Gleeson, J.F.; Alvarez-Jimenez, M.; McGorry, P.D.; Jackson, H.J. 2015: Therapy contamination as a measure of therapist treatment adherence in a trial of cognitive behaviour therapy versus befriending for psychosis. Behavioural and Cognitive PsychoTherapy 43(3): 314-327

Zidek, W. 2012: Therapy control: is my patient's medication up to date?. MMW Fortschritte der Medizin 154(20): 51-52

Ali, M.; White, J.; Lee, C.-H.; Palmer, J.L.; Smith-Palmer, J.; Fakhoury, W.; Valentine, W.J. 2008: Therapy conversion to biphasic insulin aspart 30 improves long-term outcomes and reduces the costs of type 2 diabetes in Saudi Arabia. Journal of Medical Economics 11(4): 651-670

Serinken, M.; Dursunoğlu, Nşe.; Cimrin, A.H. 2009: Therapy costs of adult patients admitting to emergency unit of a university hospital with asthma acute attack. Tuberkuloz Ve Toraks 57(2): 198-204

Hilfrich, J.; Jänicke, F. 2002: Therapy decision - patient participation?. Onkologie 25(Suppl 5): 25-27

Anonymous 2012: Therapy deficit. Nature 489(7417): 473-474

Lanka, V.; Cudkowicz, M. 2008: Therapy development for ALS: lessons learned and path forward. Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 9(3): 131-140

Smith, D.H.; Hicks, R.; Povlishock, J.T. 2013: Therapy development for diffuse axonal injury. Journal of Neurotrauma 30(5): 307-323

Bertoni, C. 2013: Therapy development for neuromuscular diseases: translating hope into promise. Future Neurology 8(4)

Tsai, L.-K. 2012: Therapy development for spinal muscular atrophy in SMN independent targets. Neural Plasticity 2012: 456478

Edwards, M.J. 2008: Therapy directed against thymic stromal lymphopoietin. Drug News and Perspectives 21(6): 312-316

Nakano, E.V.; Hinckley, J. 2010: Therapy discharge becomes part of the life story. Topics in Stroke Rehabilitation 17(1): 39-46

Shubert, J. 2012: Therapy dogs and stress management assistance during disasters. U.S. Army Medical Department Journal 2012: 74-78

Nahm, N.; Lubin, J.; Lubin, J.; Bankwitz, B.K.; Castelaz, M.; Chen, X.; Shackson, J.C.; Aggarwal, M.N.; Totten, V.Y. 2012: Therapy dogs in the emergency department. Western Journal of Emergency Medicine 13(4): 363-365

Gillies, E.P. 1948: Therapy dramatics for the public school-room. Nervous Child 7(3): 328-336

Pusch, T.; Pasipanodya, J.G.; Hall, R.G.; Gumbo, T. 2014: Therapy duration and long-term outcomes in extra-pulmonary tuberculosis. Bmc Infectious Diseases 14: 115

Satger, B.; Blaise, S.; Fontaine, M.èl.; Yver, J.; Allenet, B.ît.; Baudrant, M.; Pernod, G.; Bosson, J.-L. 2009: Therapy education for patients receiving oral anti-coagulants vitamin K antagonists. Presse Medicale 38(12): 1780-1787

Keske-Soares, M.ár.; Brancalioni, A.R.; Marini, C.; Pagliarin, K.C.; Ceron, M.I. 2008: Therapy effectiveness for phonological disorders with different therapeutic approaches. Pro-Fono: Revista de Atualizacao Cientifica 20(3): 153-159

Shao, J.; Tang, J.; Ji, J.; Zhou, W. 2012: Therapy effects of gold nanorods on the CNE-1 nasopharyngeal carcinoma cell line. Drug Design Development and Therapy 6: 297-301

Mereles, D.; Wanker, E.E.; Katus, H.A. 2008: Therapy effects of green tea in a patient with systemic light-chain amyloidosis. Clinical Research in Cardiology: Official Journal of the German Cardiac Society 97(5): 341-344

Basso, A.; Macis, M. 2011: Therapy efficacy in chronic aphasia. Behavioural Neurology 24(4): 317-325

Taliani, G.; Rucci, P.; Biliotti, E.; Cirrincione, L.; Aghemo, A.; Alberti, A.; Almasio, P.L.; Bartolozzi, D.; Caporaso, N.; Coppola, R.; Chiaramonte, M.; Floreani, A.; Gaeta, G.B.; Persico, M.; Secchi, G.; Versace, I.; Zacharia, S.; Mele, A. 2007: Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection. Journal of Viral Hepatitis 14(12): 875-882

Hu, Z.-Y.; Zhang, N.-X.; Han, J.-Y. 2009: Therapy experience of severe N-hexane poisoning with peripheral nerve injury. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 27(6): 361-363

van Lelyveld, S.F.L.; Nijhuis, M.; Baatz, F.; Wilting, I.; van den Bergh, W.M.; Kurowski, M.; de Jong, D.; Hoepelman, A.I.M.; Wensing, A.M.J. 2010: Therapy failure following selection of enfuvirtide-resistant HIV-1 in cerebrospinal fluid. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 50(3): 387-390

Pingen, M.; Nouwen, J.L.; Dinant, S.; Albert, J.; Mild, M.; Brodin, J.; Simen, B.B.; Walsh, S.; Kayser, M.; van der Ende, M.E.; Schutten, M.; Boucher, C.A.B. 2012: Therapy failure resulting from superinfection by a drug-resistant HIV variant. Antiviral Therapy 17(8): 1621-1625

Lanctôt, K.L.; Rajaram, R.D.; Herrmann, N. 2009: Therapy for Alzheimer's Disease: how Effective are Current Treatments?. Therapeutic Advances in Neurological Disorders 2(3): 163-180

Shimohama, S. 2013: Therapy for Alzheimer-type dementia-status quo and future considerations. Hokkaido Journal of Medical Science 88(2-3): 59-61

Karakurt, G.; Silver, K.E. 2014: Therapy for Childhood Sexual Abuse Survivors using Attachment and Family Systems Theory Orientations. American Journal of Family Therapy 42(1): 79-91

Einollahi, B. 2012: Therapy for HBV Infection in Hemodialysis Patients: Is it Possible?. Hepatitis Monthly 12(3): 153-157

Peters, B.S.; Conway, K. 2011: Therapy for HIV: past, present, and future. Advances in Dental Research 23(1): 23-27

Graham, D.Y.; Lu, H.; Yamaoka, Y. 2008: Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond. Drugs 68(6): 725-736

Stocchi, F. 2014: Therapy for Parkinson's disease: what is in the pipeline?. Neurotherapeutics: the Journal of the American Society for Experimental Neurotherapeutics 11(1): 24-33

Herr, D.; Juhasz-Boess, I.; Solomayer, E.F. 2014: Therapy for Primary Vulvar Carcinoma. Geburtshilfe und Frauenheilkunde 74(3): 271-275

Cohen, M.; Boiangiu, C.; Abidi, M. 2010: Therapy for ST-segment elevation myocardial infarction patients who present late or are ineligible for reperfusion therapy. Journal of the American College of Cardiology 55(18): 1895-1906

Hamama, L. 2010: Therapy for a healthy sibling of a child diagnosed with cancer: a case study. Journal of Psychosocial Oncology 28(3): 302-319

Nakasone, C.; Touyama, M.; Namisato, S.; Okudaira, S.; Fujita, J. 2010: Therapy for acute exacerbation of bronchial asthma using noninvasive positive pressure ventilation by critical care ventilator. Nihon Kokyuki Gakkai Zasshi 48(5): 370-374

Donlan, S.M.; Quattromani, E.; Pang, P.S.; Gheorghiade, M. 2009: Therapy for acute heart failure syndromes. Current Cardiology Reports 11(3): 192-201

Meneveau, N. 2010: Therapy for acute high-risk pulmonary embolism: thrombolytic therapy and embolectomy. Current Opinion in Cardiology 25(6): 560-567

Chen, C.; Xia, S.-H.; Chen, H.; Li, X.-H. 2008: Therapy for acute pancreatitis with platelet-activating factor receptor antagonists. World Journal of Gastroenterology 14(30): 4735-4738

Kawaguchi, T.; Spencer, D.B.; Mochizuki, M. 2008: Therapy for acute retinal necrosis. Seminars in Ophthalmology 23(4): 285-290

Erwin, R.L. 2010: Therapy for advanced stage cancer: what do patients want and expect? a patient advocate's perspective. Oncologist 15(Suppl 1): 11-12

Akanashi, T. 2009: Therapy for alcohol abuse. Seishin Shinkeigaku Zasshi 111(7): 875-880

Jaurigue, M.M.; Cappell, M.S. 2014: Therapy for alcoholic liver disease. World Journal of Gastroenterology 20(9): 2143-2158

Minai, O.A.; Stoller, J.K. 2000: Therapy for alpha1-antitrypsin deficiency: pharmacology and clinical recommendations. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 13(2): 135-147

Stollewerk, D. 2008: Therapy for ambulatory infectious pneumonia. Pneumologie 62(12): 744; Author Reply 744

Maun, R.A. 1981: Therapy for ankylosing spondylitis. Western Journal of Medicine 134(4): 364

Pál, Z.; Boczán, J.; Bereznai, B.; Lovas, G.áb.; Molnár, M.ár.J. 2011: Therapy for anti-MuSK antibody positive myasthenia gravis. Orvosi Hetilap 152(39): 1586-1589

DeZern, A.E.; Guinan, E.C. 2011: Therapy for aplastic anemia. HEMATOLOGY. American Society of Hematology. Education Program 2011: 82-83

Ishida, S.; Kimura, H. 2009: Therapy for atypical facial pain. Nihon Rinsho. Japanese Journal of Clinical Medicine 67(9): 1803-1809

Spinney, L. 2007: Therapy for autistic children causes outcry in France. Lancet 370(9588): 645-646

Perumbeti, A.; Malik, P. 2010: Therapy for beta-globinopathies: a brief review and determinants for successful and safe correction. Annals of the new York Academy of Sciences 1202: 36-44

Hall, C.Breese. 2007: Therapy for bronchiolitis: when some become none. New England Journal of Medicine 357(4): 402-404

Frere, C.; Debourdeau, P.; Hij, A.; Cajfinger, F.; Nonan, M.N.'G.; Onan, M.N.'G.; Panicot-Dubois, L.; Dubois, C.; Farge, D. 2014: Therapy for cancer-related thromboembolism. Seminars in Oncology 41(3): 319-338

He, N.; Wang, T.; Jiang, L.; Wang, D.; Hu, Y.; Zhang, L. 2010: Therapy for cerebral ischemic injury with erythropoietin-containing nanoparticles. Journal of Nanoscience and Nanotechnology 10(8): 5320-5323

Seretny, M.; Colvin, L.; Fallon, M. 2013: Therapy for chemotherapy-induced peripheral neuropathy. JAMA 310(5): 537-538

Mackensen, F.; Lutz, T. 2011: Therapy for childhood uveitis: biologics: too often--too late?. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 108(3): 213-221

Zhang, D.-Z. 2008: Therapy for cholestasis. Zhonghua Gan Zang Bing Za Zhi 16(8): 577-579

Berentsen, S.ør. 2013: Therapy for chronic cold agglutinin disease: perspective for further improvements. Blood Transfusion 11(2): 167-168

Wan, M.-b. 2012: Therapy for chronic hepatitis B: can we reject combination therapy. Zhonghua Gan Zang Bing Za Zhi 20(2): 86-88

Orito, E. 2007: Therapy for chronic hepatitis B: relationship between HBV genotype and efficacy or resistance of anti-viral therapy. Nihon Shokakibyo Gakkai Zasshi 104(10): 1459-1464

Cowan, M.L.; Thomas, H.C.; Foster, G.R. 2011: Therapy for chronic viral hepatitis: current indications, optimal therapies and delivery of care. Clinical Medicine 11(2): 184-189

Chen, N.; Li, H.; Zhao, L.-Y.; Liu, J.-B.; Huang, Q.; Wang, T.-H.; Hao, X.-M. 2009: Therapy for clearing heat and resolving phlegm in treatment of systemic inflammatory response syndrome in acute deterioration stage of chronic obstructive pulmonary disease: a randomized controlled trial. Zhong Xi Yi Jie he Xue Bao 7(2): 105-109

Chang, A.B. 2011: Therapy for cough: where does it fall short?. Expert Review of Respiratory Medicine 5(4): 503-513

Davis, P.B. 2011: Therapy for cystic fibrosis--the end of the beginning?. New England Journal of Medicine 365(18): 1734-1735

Terashi, H. 2008: Therapy for diabetic foot ulcers or gangrene with/without PAD. Nihon Hansenbyo Gakkai Zasshi 77(3): 237-241

Calabek, B.; Callaghan, B.; Feldman, E.L. 2014: Therapy for diabetic neuropathy: an overview. Handbook of Clinical Neurology 126: 317-333

Cheson, B.D. 2013: Therapy for diffuse large B-cell lymphoma: getting personal. Lancet 381(9880): 1793-1794

Devlieger, R.; Hindryckx, A.; Van Mieghem, T.; Debeer, A.; De Catte, L.; Gewillig, M.; Gucciardo, L.; Deprest, J.; Meyns, B. 2009: Therapy for foetal pericardial tumours: survival following in utero shunting, and literature review. Fetal Diagnosis and Therapy 25(4): 407-412

Denning, D.W.; Hope, W.W. 2010: Therapy for fungal diseases: opportunities and priorities. Trends in Microbiology 18(5): 195-204

Inada, T. 2010: Therapy for genetic disease by targeting posttranscriptional regulation. Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 8): 613-618

Munshi, A.; Jalali, R. 2009: Therapy for glioma: Indian perspective. Indian Journal of Cancer 46(2): 127-131

Taniguchi, A. 2008: Therapy for gout and pseudogout. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 97(10): 2424-2429

Weil, W.B. 2007: Therapy for head lice. Pediatrics 120(3): 688; Author Reply 689

Cerqueira Gomes, M. 1948: Therapy for heart failure. Jornal do Medico 12(305): 533-544

Bissell, D.M. 2011: Therapy for hepatic fibrosis: revisiting the preclinical models. Clinics and Research in Hepatology and Gastroenterology 35(8-9): 521-525

Mohanty, A.; Erqou, S.; McGinnis, K.A.; Vanasse, G.; Freiberg, M.S.; Sherman, K.E.; Butt, A.A. 2013: Therapy for hepatitis C virus infection increases survival of patients with pretreatment anemia. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 11(6): 741-7.E3

Dammacco, F.; Sansonno, D. 2013: Therapy for hepatitis C virus-related cryoglobulinemic vasculitis. New England Journal of Medicine 369(11): 1035-1045

Hoofnagle, J.H.; Sherker, A.H. 2014: Therapy for hepatitis C--the costs of success. New England Journal of Medicine 370(16): 1552-1553

Ryder, S.; Rizzi, P.; Karani, J.; Williams, R. 1995: Therapy for hepatocellular-carcinoma (review). International Journal of Oncology 6(5): 1113-1122

Ananthanarayanan, M. 2007: Therapy for hepatocyte transporter trafficking mutations: the time is now. Hepatology 45(6): 1340-1342

Powell, H. 2009: Therapy for horses with chronic progressive lymphoedema. Veterinary Record 165(25): 758

Hayashi, K.; Ueshima, S.; Ouchida, M.; Mashimo, T.; Nishiki, T.; Sendo, T.; Serikawa, T.; Matsui, H.; Ohmori, I. 2011: Therapy for hyperthermia-induced seizures in Scn1a mutant rats. Epilepsia 52(5): 1010-1017

Charpy, J. 1948: Therapy for infantile eczemas by the combination of unsaturated fatty acids and pyridoxine. Bulletin de la Societe Francaise de Dermatologie et de Syphiligraphie 55(2): 117-119

Manson McManamy, M.E.; Hakre, S.; Verdin, E.M.; Margolis, D.M. 2014: Therapy for latent HIV-1 infection: the role of histone deacetylase inhibitors. Antiviral Chemistry and ChemoTherapy 23(4): 145-149

Perkins, R. 1997: Therapy for lesbians?. Journal of Lesbian Studies 1(2): 257-271

Grabowski, G. 2013: Therapy for lysosomal acid lipase deficiency: replacing a missing link. Hepatology 58(3): 850-852

Beck, M. 2010: Therapy for lysosomal storage disorders. Iubmb Life 62(1): 33-40

Casella, R. 2010: Therapy for male patients with sexual dysfunction. Therapeutische Umschau. Revue Therapeutique 67(3): 123-128

Kadowaki, N.; Kitawaki, T.; Hirai, M. 2011: Therapy for malignancies and inflammatory disorders by modulating human dendritic cell functions. Japanese Journal of Clinical Hematology 52(7): 497-504

Shiyovich, A. 2013: Therapy for mental stress-induced myocardial ischemia. JAMA 310(13): 1401

Snyder, K.M.; Mackall, C.L. 2007: Therapy for metastatic ESFT: is it time to ask new questions?. Pediatric Blood and Cancer 49(2): 115-116

Boyle, G.M. 2011: Therapy for metastatic melanoma: an overview and update. Expert Review of Anticancer Therapy 11(5): 725-737

Rossi, R.E.; Massironi, S.; Conte, D.; Peracchi, M. 2014: Therapy for metastatic pancreatic neuroendocrine tumors. Annals of Translational Medicine 2(1): 8

Soyka, D. 1987: Therapy for migraine-the current state of the art and perspectives. Schmerz 1(2): 92-101

Símová, J.; Indrová, M.; Bieblová, J.; Mikysková, R.; Bubeník, J.; Reinis, M. 2010: Therapy for minimal residual tumor disease: beta-galactosylceramide inhibits the growth of recurrent HPV16-associated neoplasms after surgery and chemotherapy. International Journal of Cancer 126(12): 2997-3004

Jurkovic, R.; Holly, D.; Siebert, T.; Strecha, J. 2012: Therapy for missing lower medial incisor by means of reduced diameter implants. Journal of Oral Implantology 38(2): 171-175

Wong, C.C.; Johnson, M.H. 2014: Therapy for mitochondrial genetic disease: are we at the thin end of the wedge?. Reproductive Biomedicine Online 29(2): 147-149

Nomura, S. 2006: Therapy for mood disorders. Seishin Shinkeigaku Zasshi 108(11): 1244-1248

Giugliani, R.; Herber, S.; Lapagesse, L.; de Pinto, C.; Baldo, G. 2014: Therapy for mucopolysaccharidosis VI: (Maroteaux-Lamy syndrome) present status and prospects. Pediatric Endocrinology Reviews: Per 12(Suppl 1): 152-158

Croft, S.; Marshall, J.; Pring, T.; Hardwick, M. 2011: Therapy for naming difficulties in bilingual aphasia: which language benefits?. International Journal of Language and Communication Disorders 46(1): 48-62

Chen, C.-M. 2014: Therapy for neonatal hyperoxia-induced lung injury. Pediatrics and Neonatology 55(5): 329-330

Arnett, A.L.H.; Chamberlain, J.R.; Chamberlain, J.S. 2009: Therapy for neuromuscular disorders. Current Opinion in Genetics and Development 19(3): 290-297

Hattori, T.; Nakano, K.; Kawakami, T.; Tamura, A.; Ara, T.; Wang, P.L. 2009: Therapy for nifedipine-induced gingival overgrowth by Saireito in rats. European Journal of Medical Research 14(11): 497-501

Bitting, R.L.; Madden, J.; Armstrong, A.J. 2011: Therapy for non-clear cell histologies in renal cancer. Current Clinical Pharmacology 6(3): 169-180

D'Agostino, D.; Racioppi, M.; Filianoti, A.; Di Gianfrancesco, L.; Codolo, G.; Fassan, M.; Munari, F.; Rugge, M.; D'Elios, M.M.; de Bernard, M.; Pagano, F.; Bassi, P. 2012: Therapy for non-muscle invasive bladder cancer: HP-NAP. Urologia 79(2): 142-148

Moseley, R.H. 2008: Therapy for nonalcoholic fatty liver disease. Journal of Clinical Gastroenterology 42(4): 332-335

Thurtell, M.J.; Leigh, R.John. 2010: Therapy for nystagmus. Journal of Neuro-Ophthalmology: the Official Journal of the North American Neuro-Ophthalmology Society 30(4): 361-371

Bagger, J.I.; Christensen, M.; Knop, F.K.; Vilsbøll, T. 2011: Therapy for obesity based on gastrointestinal hormones. Review of Diabetic Studies: Rds 8(3): 339-347

De-la-Torre, A.; Stanford, M.; Curi, A.; Jaffe, G.J.; Gomez-Marin, J.E. 2011: Therapy for ocular toxoplasmosis. Ocular Immunology and Inflammation 19(5): 314-320

Garweg, J.G.; Stanford, M.R. 2013: Therapy for ocular toxoplasmosis--the future. Ocular Immunology and Inflammation 21(4): 300-305

Lancet, J.E.; Giralt, S. 2008: Therapy for older AML patients: the role of novel agents and allogeneic stem cell transplant. Journal of the National Comprehensive Cancer Network: Jnccn 6(10): 1017-1025

Sampath, D.; Garcia-Manero, G. 2012: Therapy for older patients with acute myeloblastic leukemia: a problem in search of a solution. Leukemia and Lymphoma 53(6): 1013-1014

Guan, J.; Ni, D.; Wang, J.; Zhu, Y.; Xu, C.; Chien, X.; Liu, J. 2010: Therapy for olfactory disorder associated with URTi along with nasal and accessory nasal diseases. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 24(11): 484-488

Hayashi, T.; Sumida, T. 2008: Therapy for osteoarthritis. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 97(10): 2430-2436

Chou, A.J.; Geller, D.S.; Gorlick, R. 2008: Therapy for osteosarcoma: where do we go from here?. Paediatric Drugs 10(5): 315-327

Bagga, A.; Sinha, A.; Dragon-Durey, M-Agnes. 2014: Therapy for patients with antibodies to complement factor H associated HUS. Pediatric Nephrology 29(5): 939-940

Jessen, F. 2014: Therapy for patients with dementia. Treatment strategies in the elderly. Der Internist 55(7): 769-774

Matsunaga, H. 2011: Therapy for patients with obsessive-compulsive spectrum disorder--special reference to the pharmacotherapy and the trends in DSM-5. Seishin Shinkeigaku Zasshi 113(10): 983-984

Miltényi, Z.óf.; Simon, Z.óf.; Páyer, E.; Váróczy, L.ás.ó; Gergely, L.; Illés, A.ád. 2010: Therapy for patients with primary refractory and relapsed Hodgkin-lymphoma--our experience. Orvosi Hetilap 151(5): 172-178

Sklar, C.; Wolden, S. 2011: Therapy for pediatric brain tumors and the risk of growth hormone deficiency. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 29(36): 4743-4744

Mays, R.J.; Regensteiner, J.G. 2014: Therapy for peripheral artery disease: gaps in treating patients with claudication. Circulation 130(12): 929-931

Keedy, K.S.; Margolis, D.M. 2010: Therapy for persistent HIV. Trends in Pharmacological Sciences 31(5): 206-211

Feldman, C.; Anderson, R. 2009: Therapy for pneumococcal bacteremia: monotherapy or combination therapy?. Current Opinion in Infectious Diseases 22(2): 137-142

Grantham, J.J. 2008: Therapy for polycystic kidney disease? It's water, stupid!. Journal of the American Society of Nephrology: Jasn 19(1): 1-7

Shah, V. 2009: Therapy for portal hypertension: what is our pipeline?. Hepatology 49(1): 4-5

Najavits, L.M. 2013: Therapy for posttraumatic stress and alcohol dependence. JAMA 310(22): 2457-2458

Ramasubbu, R. 2011: Therapy for prevention of post-stroke depression. Expert Opinion on PharmacoTherapy 12(14): 2177-2187

Satoh, K.; Sugano, K. 2014: Therapy for prevention of upper gastrointestinal bleeding in patients receiving anti-thrombotic therapy. Nihon Rinsho. Japanese Journal of Clinical Medicine 72(7): 1325-1330

White, M.D.; Mallucci, G.R. 2009: Therapy for prion diseases: Insights from the use of RNA interference. Prion 3(3): 121-128

Tax, H.R. 1945: Therapy for pronated feet in childhood. Journal of the National Association of Chiropodists 35(11): 18-23

Wagenlehner, F.M.E.; Weidner, W.; Naber, K.G. 2007: Therapy for prostatitis, with emphasis on bacterial prostatitis. Expert Opinion on PharmacoTherapy 8(11): 1667-1674

Sharvill, J. 2009: Therapy for psychiatric therapy. British Journal of General Practice: the Journal of the Royal College of General Practitioners 59(568): 869-870

Mathai, S.C.; Hassoun, P.M. 2009: Therapy for pulmonary arterial hypertension associated with systemic sclerosis. Current Opinion in Rheumatology 21(6): 642-648

Taichman, D.B. 2008: Therapy for pulmonary arterial hypertension: the more, the merrier?. Annals of Internal Medicine 149(8): 583-585

Wen, P.Y. 2010: Therapy for recurrent high-grade gliomas: does continuous dose-intense temozolomide have a role?. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 28(12): 1977-1979

Han, Y.; Zhu, J.-y. 2012: Therapy for refractory primary biliary cirrhosis. Zhonghua Gan Zang Bing Za Zhi 20(5): 330-332

Qiu, S.-l.; Jin, M.; Yi, J.-h.; Zhu, T.-g.; Quan, X.; Liang, Y. 2009: Therapy for replenishing qi, nourishing yin and promoting blood circulation in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a randomized controlled trial. Zhong Xi Yi Jie he Xue Bao 7(7): 616-621

Baughman, R.P.; Nunes, H. 2012: Therapy for sarcoidosis: evidence-based recommendations. Expert Review of Clinical Immunology 8(1): 95-103

Deutschman, C.S. 2013: Therapy for sepsis: Einstein once said.. British Journal of Anaesthesia 111(5): 693-695

Takasaki, Y. 2008: Therapy for seronegative spondyloarthropathy. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 97(10): 2437-2443

Abe, R. 2011: Therapy for skin disease using bone marrow cells. Nihon Rinsho Men'eki Gakkai Kaishi 34(2): 85-90

Maun, M.E.; Jewell, F.C.; Dunning, W.F. 1946: Therapy for soft tissue sarcomas; an experimental study. Surgery Gynecology and Obstetrics 83(5): 653-656

Curry, S.J.; Mermelstein, R.J.; Sporer, A.K. 2009: Therapy for specific problems: youth tobacco cessation. Annual Review of Psychology 60: 229-255

Carron, P.; Van Praet, L.; Jacques, P.; Elewaut, D.; Van den Bosch, F. 2012: Therapy for spondyloarthritis: the role of extra-articular manifestations (eye, skin). Rheumatic Diseases Clinics of North America 38(3): 583-600

Sarbaziha, R.; Sedlak, T.; Shufelt, C.; Mehta, P.K.; Merz, C.N.B. 2012: Therapy for stable angina in women. P and T: a Peer-Reviewed Journal for Formulary Management 37(7): 400-404

Saab, G.; Whaley-Connell, A.T.; Khanna, R.; Sowers, J.R. 2007: Therapy for the altered mineral metabolism of chronic kidney disease: implications for vascular calcification. Therapeutic Advances in Cardiovascular Disease 1(2): 107-112

Valayannopoulos, V.; Wijburg, F.A. 2011: Therapy for the mucopolysaccharidoses. Rheumatology 50(Suppl 5): V49-V59

Kondo, K. 2014: Therapy for thymic epithelial tumors. General Thoracic and Cardiovascular Surgery 62(8): 468-474

Remmert, S.; Sesterhenn, A. 2014: Therapy for tongue cancer - reconstruction with buccinator flap. Laryngo- Rhino- Otologie 93(5): 306-307

Shaw, E.; Tofler, G.H.; Buckley, T.; Bajorek, B.; Ward, M. 2009: Therapy for triggered acute risk prevention: a study of feasibility. Heart Lung and Circulation 18(5): 347-352

Skorjanec, S.; Dolovski, Z.; Kocman, I.; Brcic, L.; Blagaic Boban, A.; Batelja, L.; Coric, M.; Sever, M.; Klicek, R.; Berkopic, L.; Radic, B.; Drmic, D.; Kolenc, D.; Ilic, S.; Cesarec, V.; Tonkic, A.; Zoricic, I.; Mise, S.; Staresinic, M.; Ivica, M.; Lovric Bencic, M.; Anic, T.; Seiwerth, S.; Sikiric, P. 2009: Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide BPC 157, atropine, ranitidine, and omeprazole. Digestive Diseases and Sciences 54(1): 46-56

Gimbel, M.I.; Delman, K.A.; Zager, J.S. 2008: Therapy for unresectable recurrent and in-transit extremity melanoma. Cancer Control: Journal of the Moffitt Cancer Center 15(3): 225-232

Elder, J.S. 2008: Therapy for vesicoureteral reflux: antibiotic prophylaxis, urotherapy, open surgery, endoscopic injection, or observation?. Current Urology Reports 9(2): 143-150

Janssens, U.; Burchardi, H.; Duttge, G.; Erchinger, R.; Gretenkort, P.; Mohr, M.; Nauck, F.; Rothärmel, S.; Salomon, F.; Schmucker, P.; Simon, A.; Stopfkuchen, H.; Valentin, A.; Weller, N.; Neltzke, G. 2013: Therapy goal modification and therapy limit in intensive care medicine. Medizinische Klinik Intensivmedizin und Notfallmedizin 108(1): 47-52

Rose, J.F.; McGuire, C. 2008: Therapy horses school nurses in emotional fitness. Rn 71(10): 18-20

Sréter, L.íd. 2009: Therapy in Hodgkin disease and non-Hodgkin lymphomas. Orvosi Hetilap 150(14): 651-655

Vas, T.; Kovács, T.; Késoi, I.án.; Sági, B.áz.; Degrell, P.ét.; Wittmann, I.án.; Nagy, J. 2011: Therapy in IgA nephropathy--when and how to do it. Orvosi Hetilap 152(51): 2039-2046

Singh, V.; Cohen, M.G. 2014: Therapy in ST-elevation myocardial infarction: reperfusion strategies, pharmacology and stent selection. Current Treatment Options in Cardiovascular Medicine 16(5): 302

Shephard, R.J. 1971: Therapy in a fog. Canadian Family Physician Medecin de Famille Canadien 17(4): 51-53

Skjeldal, O.H.; Capjon, H.; Dahl, A.; Diseth, T.H. 2009: Therapy in a subtropical climate for children with cerebral palsy. Evidence of physical and psychosocial effects?. Acta Paediatrica 98(4): 670-674

Schwartz, G. 1946: Therapy in acute coronary artery disease. Medical World 159(12): 727-731

Conway, J.P. 1948: Therapy in acute infectious disease in children. Wisconsin Medical Journal 47(4): 395-398

Mahr, T.A. 2007: Therapy in allergic rhinoconjunctivitis: new horizons. Allergy and Asthma Proceedings 28(4): 404-409

Isla Pera, P. 2011: Therapy in diabetes education. Where are we?. Revista de Enfermeria 34(6): 32-38

Dienemann, H.C.; Eberhardt, W.; Fietkau, R.; Reck, M. 2008: Therapy in elderly patients. Onkologie 31(Suppl 3): 15-22

Pasquali, R.; Gambineri, A. 2014: Therapy in endocrine disease: treatment of hirsutism in the polycystic ovary syndrome. European Journal of Endocrinology 170(2): R75-R90

Wilke, H.; Stahl, M. 2009: Therapy in gastric cancer. from an oncological perspective. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 80(11): 1023-1027

Hosztafi, S.áa.; Fürst, Z. 2014: Therapy in heroin addiction. Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet Lapja 16(3): 127-140

Reiss, O. 1948: Therapy in pediatric practice. Annals of Western Medicine and Surgery 2(1): 38

Lee, A.E. 1947: Therapy in pelvic inflammatory disease. Medical Record 160(6): 355-357

Meijvis, S.C.A.; Grutters, J.C.; Thijsen, S.F.; Rijkers, G.T.; Biesma, D.H.; Endeman, H. 2011: Therapy in pneumonia: what is beyond antibiotics?. Netherlands Journal of Medicine 69(1): 21-26

Woessmann, W.; Lisfeld, J.; Burkhardt, B. 2013: Therapy in primary mediastinal B-cell lymphoma. New England Journal of Medicine 369(3): 282

Cashen, A.F.; Christian, B.A.; Bartlett, N.L. 2013: Therapy in primary mediastinal B-cell lymphoma. New England Journal of Medicine 369(3): 282-283

Forloni, G.; Artuso, V.; Roiter, I.; Morbin, M.; Tagliavini, F. 2013: Therapy in prion diseases. Current Topics in Medicinal Chemistry 13(19): 2465-2476

Krammer, C.; Vorberg, I.; Schätzl, H.M.; Gilch, S. 2009: Therapy in prion diseases: from molecular and cellular biology to therapeutic targets. Infectious Disorders Drug Targets 9(1): 3-14

Cernea, S.; Raz, I. 2011: Therapy in the early stage: incretins. Diabetes Care 34(Suppl 2): S264-S271

Woolley, L.F. 1949: Therapy in the private practice of psychiatry. Southern Medical Journal 42(8): 707-712

Cramer, R.R. 1946: Therapy in the treatment of congenital duodonal atresia. Medical World 64: 206-208

Yellowlees, P.M.; Holloway, K.M.; Parish, M.B. 2012: Therapy in virtual environments--clinical and ethical issues. Telemedicine Journal and E-Health: the Official Journal of the American Telemedicine Association 18(7): 558-564

Barry, J.G.; Ross, S.A.; Woehrle, J. 2012: Therapy incorporating a dynamic wrist-hand orthosis versus manual assistance in chronic stroke: a pilot study. Journal of Neurologic Physical Therapy: Jnpt 36(1): 17-24

Schultheiss, M.; von Baer, A.; Gebhard, F.; Kinzl, L.; Arand, M. 2007: Therapy indications and options for skeletal metastases. Der Urologe. Ausg. a 46(8): 897-903

Riccardi, F.; Rizzo, M.; Festino, L.; Ambrosio, F.; Molino, C.; Uomo, G.; Cartenì, G. 2012: Therapy innovation for the treatment of pancreatic neuroendocrine tumors. Expert Opinion on Therapeutic Targets 16(Suppl 2): S91-102

Raymond, E.; Hobday, T.; Castellano, D.; Reidy-Lagunes, D.; García-Carbonero, R.ío.; Carrato, A. 2011: Therapy innovations: tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors. Cancer Metastasis Reviews 30(Suppl 1): 19-26

Strätling, M.W.; Sedemund-Adib, B. 2013: Therapy limitations in intensive care medicine. Der Anaesthesist 62(6): 489-490

Wang, Y.-F.; Que, H.-F.; Xiang, H.-Y.; Xu, J.-N.; Tang, H.-J. 2008: Therapy mainly for strengthening healthy energy to promote blood circulation in treating 112 diabetic patients with gangrene. Zhong Xi Yi Jie he Xue Bao 6(10): 1005-1009

Bölükbas, S.; Kudelin, N.; Dönges, T.; Schirren, J. 2010: Therapy management of chylothorax. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 81(3): 255-263; Quiz: 264-265

McConnell, K.; Johnston, L.; Kerr, C. 2012: Therapy management of the upper limb in children with cerebral palsy: a cross-sectional survey. Developmental Neurorehabilitation 15(5): 343-350

Gargini, R.; García-Escudero, V.; Izquierdo, M. 2011: Therapy mediated by mitophagy abrogates tumor progression. Autophagy 7(5): 466-476

Schuster, M.; Berghaus, A. 2013: Therapy methods for senescence effects on speech. MMW Fortschritte der Medizin 155(1): 50-52

Willey, V.J.; Bullano, M.F.; Shoetan, N.N.; Gandhi, S.K. 2010: Therapy modifications and low-density lipoprotein cholesterol goal attainment rates associated with the initiation of generic simvastatin. Current Medical Research and Opinion 26(1): 121-128

Zelante, A.; Borgoni, R.; Galuppi, C.; Cifalà, V.; Melchiorri, L.; Gullini, S.; Baricordi, O.; Rizzo, R. 2011: Therapy modifies HLA-G secretion differently in Crohn's disease and ulcerative colitis patients. Inflammatory Bowel Diseases 17(8): E94-E95

Rempp, H.ör.; Unterberg, J.; Hoffmann, R.üd.; Pereira, P.L.; Schick, F.; Claussen, C.D.; Clasen, S. 2013: Therapy monitoring of magnetic resonance-guided radiofrequency ablation using T1- and T2-weighted sequences at 1.5 T: reliability of estimated ablation zones. Investigative Radiology 48(6): 429-436

Grandl, S.; Ingrisch, M.; Hellerhoff, K. 2014: Therapy monitoring of neoadjuvant therapy with MRI. RECIST and functional imaging. Der Radiologe 54(3): 233-240

Padhani, A.R.; Makris, A.; Gall, P.; Collins, D.J.; Tunariu, N.; de Bono, J.S. 2014: Therapy monitoring of skeletal metastases with whole-body diffusion MRi. Journal of Magnetic Resonance Imaging: Jmri 39(5): 1049-1078

Bodmann, K.-F.; Heizmann, W.R.; von Eiff, C.; Petrik, C.; Löschmann, P.-A.; Eckmann, C. 2012: Therapy of 1,025 severely ill patients with complicated infections in a German multicenter study: safety profile and efficacy of tigecycline in different treatment modalities. ChemoTherapy 58(4): 282-294

Fan, H.; Zhu, H.-L.; Li, S.X.; Lu, X.-C.; Yang, Y.; Yao, S.-Q. 2008: Therapy of 17 cases of idiopathic thrombocytopenia purpura by amifostine. Zhongguo Shi Yan Xue Ye Xue Za Zhi 16(1): 192-196

Matthis, M. 2009: Therapy of ADHD. British institute recommends: drugs only in severe cases. MMW Fortschritte der Medizin 151(7): 16

Levin, J.R.; Dorfner, W.L.; Carroll, P.J.; Schelter, E.J. 2015: Control of cerium oxidation state through metal complex secondary structures. Chemical Science 6(12): 6925-6934

Ando, Y. 2011: Therapy of ATTR amyloidosis: perspective. Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis 18(Suppl 1): 182-184

Kovács, T. 2009: Therapy of Alzheimer disease. Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet Lapja 11(1): 27-33

Schmidt, R.; Neff, F.; Lampl, C.; Benke, T.; Anditsch, M.; Bancher, C.; Dal-Bianco, P.; Reisecker, F.; Marksteiner, J.; Rainer, M.; Kapeller, P.; Dodel, R. 2008: Therapy of Alzheimer's disease: current status and future development. Neuropsychiatrie: Klinik Diagnostik Therapie und Rehabilitation: Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater 22(3): 153-171

Stein, R.; Gupta, P.; Chen, X.; Cardillo, T.M.; Furman, R.R.; Chen, S.; Chang, C.-H.; Goldenberg, D.M. 2010: Therapy of B-cell malignancies by anti-HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways. Blood 115(25): 5180-5190

Nährlich, L.; Mainz, J.G.; Adams, C.; Engel, C.; Herrmann, G.; Icheva, V.; Lauer, J.; Deppisch, C.; Wirth, A.; Unger, K.; Graepler-Mainka, U.; Hector, A.; Heyder, S.; Stern, M.; Döring, G.; Gulbins, E.; Riethmüller, J. 2013: Therapy of CF-patients with amitriptyline and placebo--a randomised, double-blind, placebo-controlled phase IIb multicenter, cohort-study. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 31(4-5): 505-512

Tran, M.-C.N.; Claros, M.C.; Goldstein, E.J.C. 2013: Therapy of Clostridium difficile infection: perspectives on a changing paradigm. Expert Opinion on PharmacoTherapy 14(17): 2375-2386

Ronald, J. 1939: Therapy of Duodenal Ulcer. British Medical Journal 2(4116): 1033-1034

McLimans, W.F.; Grant, C.W. 1947: Therapy of Experimental Tsutsugamushi Disease (Scrub Typhus). Science 105(2720): 181-182

Seto, J.T.; Bengtsson, N.E.; Chamberlain, J.S. 2014: Therapy of Genetic Disorders-Novel Therapies for Duchenne Muscular Dystrophy. Current Pediatrics Reports 2(2): 102-112

Cao, B.; Hayden, F.G. 2013: Therapy of H7N9 pneumonia: current perspectives. Expert Review of AntI-Infective Therapy 11(11): 1123-1126

Mauss, S. 2009: Therapy of HIV-HBV-coinfection. MMW Fortschritte der Medizin 151(18): 49-50; 52-53

Hentrich, M.; Hoffmann, C.; Mosthaf, F.; Müller, M.; Siehl, J.; Wyen, C.; Hensel, M. 2014: Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG). Annals of hematology 93(6): 913-921

Talebi Bezmin Abadi, A. 2014: Therapy of Helicobacter pylori: present medley and future prospective. Biomed Research International 2014: 124607

Bischoff, M. 2011: Therapy of Hodgkin lymphoma: chances of remission are good, treatment tolerance needs improvement. MMW Fortschritte der Medizin 153(41): 17

Aquino, S.; Clavio, M.; Rossi, E.; Vignolo, L.; Miglino, M.; Spriano, M.; Canepa, L.; Catania, G.; Pierri, I.; Bergamaschi, M.; Gonella, R.; Marani, C.; Racchi, O.; Cavaliere, M.; Goretti, R.; Carbone, F.; Bruzzone, A.; Tassara, R.; Carella, A.Michele.; Ghio, R.; Gobbi, M. 2011: Therapy of Hodgkin's lymphoma in clinical practice: A retrospective long-term follow-up analysis. Oncology Letters 2(2): 289-295

Rostoker, G. 1998: Therapy of IgA nephropathy. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 9(4): 279-301

Lee, C.-S.; Doi, Y. 2014: Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens. Infection and ChemoTherapy 46(3): 149-164

Mecklenburg, I. 2014: Therapy of Inflammatory Bowel Disease. Praxis 103(4): 203-211

Vosoughi, R.; Freedman, M.S. 2010: Therapy of MS. Clinical Neurology and Neurosurgery 112(5): 365-385

Judge, D.P.; Dietz, H.C. 2008: Therapy of Marfan syndrome. Annual Review of Medicine 59: 43-59

Deuschl, G. 2008: Therapy of Parkinson's disease 2008. MMW Fortschritte der Medizin 150(Suppl 2): 60-63